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II. - INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
LEGG-CALVE-PERTHES’ DISEASE 
“What’s in a name? that which we call a rose 
By any other name would smell as sweet.” 
Romeo and Juliet, 11. 43 
Quoted by Perthes’, 1920. 
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II.i   Rationale for the study     
Legg-Calvé-Perthes’ syndrome is a disorder involving the hip in children that results from an 
interruption to the blood supply of the capital femoral epiphysis.  The disorder was described 
independently by Legg, Calvé, Perthes and Waldenstrom in the early twentieth century. Perthes was 
the first to describe the pathology in which he found cartilage islands with no features of infection or 
inflammation. Sundt described the ‘susceptible child’. He believed that people who were so predisposed  
would develop the disease once they sustained trauma to the hip.  
‘Trauma’ here is generically used to imply an insult to the hip that tips the balance causing the 
disorder and included either injury or infection. 
 There have been recent studies implying that there are prothrombotic tendencies in 
patients with Perthes’ disease, especially in western populations. But other studies have refuted this 
association. The existing literature has implicated the following factors:- Protein C (PrC), Protein S 
(PrS), Factor V Leiden mutation (FVL), Hypofibrinolysis, Low levels of Antithrombin III (AT)( 1 
2, 3,4,5,6,7,8,9. ) 
 In our hospital, more than 50% of our patients with Perthes’ disease come from West Bengal; 
we hypothesise that there is a locus of disease there similar to the already proven loci in Liverpool, the 
Konkan region and Kerala. A population-based study is required to prove this conclusively. 
 A previous audit of our patients revealed three sets of brothers with Perthes’ disease. This led 
us to consider that, at least in some patients, there was probably a genetic or hereditary basis for 
disease. In addition, our patients predominantly had severe disease and two had recurrent Perthes’ 
disease suggesting repeated insults. These observations are consistent with a thrombophilic etiology 
which has been proposed in the last decade. Literature reveals many studies where evaluation of some 
thrombotic traits was done, but it was not comprehensive and the findings of various studies are in 
conflict with each other. We made a comprehensive list of thrombotic factors that could be evaluated at 
our institution. These include all known factors with the exclusion of Thrombin-activable fibrinolysis 
inhibitor (TAFI). 
There is a report of more severe disease being prevalent in patients with a homozygous 
mutation for Factor V Leiden gene.10 The incidence of the F V Leiden mutation in India is much lower 
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than in the West (data from our clinical pathology lab, 2004-5 on patients who underwent the thrombotic 
work up for DVT) and Ghosh et al. who reported that an incidence of only 3% of patients with deep vein 
thrombosis (DVT) had the F V Leiden mutation in a prospective study of 432 patients from western 
India. They reported that at least 34% of them had a demonstrable cause for thrombophilia. In a study 
of patients with hepatic venous outflow tract obstruction (HVOTO) Kumar et al reported a low allele 
frequency of FVL mutation - 2% in controls and 3.4% in cases, in their study population of 59 patients. 
11, 12. This is opposed to the high incidence of Factor V Leiden mutation reported in western English 
literature where it was found to be present in up to 14.5% 13 
Extrapolating this, i.e. the severity of Perthes’ disease and presence of thrombophilia is linked, 
and that the prevalence of thrombophilic factors are different in the Indian and western populations, we 
assumed that alternative thrombotic tendencies were present in our population. So we modified the 
inclusion criteria to include patients with more severe disease and those with a family history of disease 
to increase the proportion of patients with thrombophilia in our study population. If this picked up a large 
incidence of patients with thrombophilia, we planned to extend this study to include all patients with 
Perthes’ disease. In Perthes’ disease, the focus has been on the treatment of the avascular necrosis 
after the damage has occurred.  The study of thrombophilic etiology has an attraction for the 
orthopaedic surgeon as it  opens up the possibility  of preventive treatment. 
There are no studies in India delineating the baseline values for thrombosis. Furthermore, there 
are no studies on the subset of Perthes’ disease patients. Ours is a pilot study in children with Perthes’ 
to see if they have a prothrombotic tendency. 
 
 
 
 
 
 
 
 
 12
II.ii. Aim 
To investigate the role of thrombophilia in the etiology of 
Perthes’ disease in India. 
II.iii. Objectives 
 
1. To study the genetic mutations associated with 
thrombosis in Perthes’ disease. 
2. To evaluate prothrombotic tendencies among children 
with Perthes’ disease. 
3. To geographically map the patients who formed the study 
population. 
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III. REVIEW OF 
LITERATURE 
 
It is impossible to answer the question regarding etiology.” 
 
Calve, Jacques, Sur une forme particuliere de pseudo-coxalgie greffee 
sur des deformations caracteristiques de I’extremite 
superieure du femur, Revue de Chirurgie 30:54-84, 1910. 
(English translation) EX1 
 
 
When a thing ceases to be a subject of controversy it ceases to be a 
subject of interest. 
 
William Hazlitt, English essayist and critic, 18th century.  
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III.i. History 
Tuberculosis reached epidemic proportions during the 19th century in the industrialized 
countries. Bone and joint tuberculosis was common, and its treatment formed a major part of the 
contemporary surgeons’ work. Occasionally, however, it was noted that children who were thought to 
have ‘tuberculous hip disease’ recovered quickly and with excellent function. Hugh Owen Thomas 
constructed a device for the treatment of this form of disease which survives to today as ‘the patten-
ended caliper’, and is still used by some in the treatment of Perthes’ disease. 
The treatment of choice for this ‘nonsuppurative’ type of hip disease was excision of the 
femoral head. This was advocated mainly by German surgeons and remained ‘text-book teaching’ until 
1902. Noble Smith, in London, thought that because not every case of hip disease had tuberculosis as 
its origin, excision of the femoral head should not be performed as routine treatment.  
In 1895, in Wurzburg, Professor Wilhelm Roentgen presented his discovery: “Uber eine Art von 
Strahlen” (On a New Form of Rays) at the meeting of the local Physicomedical Society. His discovery 
changed orthopaedics and, in the process, allowed Perthes’ disease to be differentiated from 
tuberculosis on radiological grounds.   
 Alban Kohler, the world‘s first professor of radiology, in Wiesbaden, in 1905, presented a case 
of flattening and later fragmentation of the femoral capital epiphysis in a child, which he thought did not 
have tuberculosis as its origin. It reminded him of an infarct (infarctiihnlich). He repeated this 
observation in 1908 when he described the condition affecting the tarsal navicular, which still bears his 
name.  
 Calvé noted a special type of ‘coxalgie’ i.e. ‘pain in the hip’ in which severe radiological 
changes did not correspond with the minimal clinical signs. He called the condition “coxalgie fruste” and 
drew the attention of his friend Sourdat to this phenomenon who published his account in 1910, 
acknowledging Calvé’s work. In 1909, Henning Waldenstrom, later to become professor of 
orthopaedics at Stockholm, gave an account of seven of his own and three of Sindig-Larsen’s patients. 
The children reported in this paper had developed an intermittent limp with little pain and no systemic 
upset. The observed radiological changes were suggested to have been brought about by tuberculosis 
of the hip interfering with the blood supply of the hip. Though Waldenstrom thought that the disease 
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was a form of tuberculosis, he concluded: “I have presented here the cause, origin and development of 
a perhaps quite common disease, which, however, has not been described before.” 
At the meeting of the American Orthopaedic Association at Hartford, Connecticut, in June 1909, 
Arthur T. Legg of Children’s hospital, Boston, presented case histories of five children. His paper was 
published the following year. He thought that this “obscure affection of the hip joint” was caused by 
trauma, disrupting the blood supply to the femoral head by a minor displacement of the epiphysis. Such 
an injury would cause a hyperemia of the neck of the femur, resulting in the thickening seen on the 
radiographs. 
In 1910, Jacques Calvé an assistant surgeon at Berck, presented his ‘Sur une forme 
particuliere de pseudocoxalgie’ 14 where he gave an account of 10 patients in whom they found no sign 
of congenital syphilis. One of his patients had both hips affected, and two were brother and sister. He 
considered the cause to be an abnormal or retarded osteogenesis, such as that brought about by 
rickets.  He felt that a low-grade infection in a thus affected hip could cause the radiologically observed 
changes. He thought that this condition was not tuberculous in origin and did not correspond with any 
previously described hip disorder. 
 Georg Clemens Perthes was professor of surgery at Leipzig, when in 1910, he presented his 
paper entitled ‘Uber Arthritis Deformans Juvenilis.’ In this detailed study, he presented 38 patients, 12 
of them with bilateral disease. He summarized the clinical picture as well as the radiological 
appearances. He thought that the condition was not tuberculosis, and trauma did not play a major part 
in its etiology. Perthes thought that Kohler’s patients in 1905 probably had the same condition as the 
patients in his own paper. At this stage, he thought that the disorder came about as a consequence of 
an incompletely healed hip joint inflammation in infancy.  By 1913, Perthes revised his views on the 
condition, which he then called “osteochondritis deformans juvenilis.”  He presented six more case 
histories and brought together the classical clinical and radiological phenomena of this ailment, which 
still hold largely true today. Perthes obtained a biopsy specimen from one of the patients and found no 
inflammatory response in the synovium or in the segment from the femoral head. Marrow and bone 
necrosis were present with intermingling of small cartilage islets. He referred to Lexer’s work when he 
formulated his new theory of the etiology: the disorder might be due to interference with the blood 
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supply of the femoral capital epiphysis, the cause of which is unknown. It was because of Perthes’ 
contributions that the condition soon came to be called Perthes’ disease. 
Other observers thought that the occasional familial occurrence of the disorder was difficult to 
reconcile with the theory of localized vascular disturbance at the upper end of the femur. Thus the 
discussion on whether Perthes’ disease was inherited or not is about a century old! 
In 1915 Allison and Moody tried and failed to reproduce the condition in rabbits by interfering with the 
blood supply to the femoral head; the reason why it is difficult to reproduce in animals is that they do not 
bear weight on the affected limb and therefore collapse does not occur. 
The 1920s saw an enormous number of publications on Perthes’ disease. This was the era of 
“osteochondritismanship” (Mercer Rang), when osteochondritis of virtually every growing epiphysis was 
‘discovered’. The term ‘osteochondritis’ was originally coined to describe the changes seen in 
congenital syphilis.  Perthes believed that several different causes could lead to the obstruction of 
arterial blood flow to the affected femoral head. He and other contemporary surgeons thought that the 
ailment could arise from several different etiologic factors operating in different individuals. 15,16. 
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III.ii. Epidemiology 
I I I . i i .a Incidence 
The epidemiology of the disease in India has largely been limited to the studies done in 
western India.  Joseph et al reported the incidence of Perthes’ disease in Vellore taluk to be 
0.4/100,000 per year in the 5-14 year age group (data provided from the Christian Medical College, 
Vellore)  and 4.4/100,000 in Udupi taluk in the same age group. 17 
Barker et al., in 1978, reported on the incidence of Perthes’ disease in three regions of England. 
They found that the incidence in the Mersey region (11.1 per 100 000 children under fifteen years) was 
twice that in Wessex (5.5) with Trent having an intermediate incidence (7.6).  18 Pillai et al in 2005 
reported that in 40 children with Perthes’ disease from South West Scotland (Dumfries and Galloway) 
the mean annual incidence of Perthes’ disease was 15.39 per 100 000 children aged 0 to 14 years. 19 
Hall and Barker in 1989 reported that the average annual incidence was 10.2 per 100,000 in boys aged 
14 years and under and 2.2 in girls. 20 
The data given below, taken from the article by Hall and Barker 21on the epidemiology of Perthes’ 
disease and other articles show the highest incidence in Liverpool and ranges of incidence between 5 – 
15/100,000 per year elsewhere. 22. 23 
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I I I . i i .b Boy :Girl Ratio 
The ratio of male to female involvement was 2.6:1 in combined cases from the data obtained 
from England and in the Indian population (unpublished data from areas in India as well as the United 
Kingdom as presented by Joseph et al) and 6.6:1 in the patients from Udipi taluk alone. The overall 
male:female ratio in 165 cases reported by Chacko et al in South India in 1986 was 2.58:1, with 
profound regional differences. 24 17 
Wynne-Davies and Gormley, in 1978, found the ratio of males to females in Edinburgh and 
Glasgow to be between 4 to 5:1 in their study of 310 patients.  25 Barker et al had an average male to 
female ratio of 3.75:1 with ranges varying from 3.4 to 4.4:1 in their study of three areas- 72 came from 
Mersey, 78 from Trent and 34 from Wessex  - of the UK, a total of 180 patients. 18 Pillai et al in 2005 
reported that in 40 children with Perthes’ disease the Male:Female ratio was 3.4:1 (31 boys and nine 
girls). 19 Hall  and Barker in 1989 reported on a total of 101 children newly diagnosed as having Perthes’ 
disease in Yorkshire. In their study, there were 84 boys and 17 girls, aged from 2 to 13 years showing a 
male female ratio of almost 5:1. 20  Most other studies have a ratio of around 4 or 5 :1 23, 22 
 
I I I . i i .c Distribution 
There are studies showing that there is an increased incidence of Perthes’ disease in the urban 
population as compared to the rural population. A survey of cases of the disease in Liverpool, England, 
during six years (1976-81), showed a remarkably steep social class gradient, from 4 per 100,000 in 
Social Class l to 26 per 100,000 in Social Class V, mainly in the inner cities. 21 Conversely, the 
population of urban children affected by the disease in two cities in South India was much less than 
 the rural population affected in the study by Joseph et al. 17,18.  
Pillai et al in 2005, reported on the spread of Perthes’ disease in 40 patients from Dumfries and 
Galloway in Southwest Scotland who were identified by a retrospective review over a period of ten 
years from 1992 to 2002. There was a direct association between the incidence of the disease and 
deprivation scores, with the highest incidence in the most deprived areas. The incidence of Perthes’ 
disease in rural Scotland is comparable with that in urban areas (15.4 per 100 000). 19 Hall and Barker 
in 1989, in their study of 101 patients, showed the rural urban distribution is as given below - wholly 
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urban - 62 , predominantly urban-27, mixed urban-6, mixed and predominantly rural-0, and wholly rural 
- 6 which shows a 62% localization in the urban population. They also reported that there was a steep 
rise in incidence from social class I to V.  20 
 
I I I . i i .d Age 
In 165 cases of Perthes’ disease observed by Chacko et al in South India in a 15-year period, 
the mean age at onset of symptoms was 9.89 years for boys and 8.71 years for girls. 24   Joseph et al in 
their study of Perthes’ disease in South India mentions that the mean age of patients in India was 
approximately 10 years as compared to 6 years on average in the UK and the US. They also mentioned 
that this was unlikely to be explained by the fact that cases may be picked up later in India than in the 
west as the age distribution of Indian patients fit the log normal curve. The possible explanations given 
for this later onset of disease was that the aetiological factors may act at a later age in Indian children 
or that the time to onset to disease was longer in Indians. 18,17 . Pillai et al in 2005 reported that in 40 
children with Perthes’ disease from South West Scotland, the mean age at diagnosis was 6.5 years. 19 
In the study by Gleuck et al in Cincinnati, the mean age of the children when Perthes’ disease was first 
diagnosed was 5.8 ± 2.7 years. 1 Thus the mean age at presentation in Indian children was about 8 
years and in other populations about 6 years.25 
 
 
 
‘ 
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III.iii. Etiology and Pathogenesis: 
Perthes’ disease is an avascular necrosis of the head of the femur in children. Various 
etiologies have been proposed for this. Since our study focuses on the thrombotic etiology for Perthes’ 
disease, this will be discussed in more detail. 
I I I . i i i .a Histopathology 
 In the study by Inoue et al, the histological appearance of 57 femoral head biopsy specimens in 
Perthes’ disease was studied. In 51 per cent of hips, histopathological changes characteristic of double 
infarction were present and there were grounds for postulating that double infarction might eventually 
occur in all cases. The findings support the concept that the deformation of the femoral head and the 
chronicity of Perthes’ disease in man may be due at least as much or even more to repeated episodes 
of infarction and the ensuing abnormalities of growth rather than mechanical factors related to weight-
bearing. In this study, they also examined canine femoral heads that were infarcted once, as well as, 
twice (after an interval of four weeks) and the human biopsies.  
In those dogs, where the femoral heads were examined after four weeks, there was evidence 
of infarction and revascularization. There were areas of living woven bone deposited on a scaffold of 
dead bone and the marrow spaces were occupied by granulation tissue. After the second infarct, these 
attempts at repair also died and showed a characteristic and diagnostic picture of two infarcts: there 
was dead woven bone superimposed on dead lamellar bone, and the marrow space was occupied by 
dead granulation tissue. The histological changes in Perthes’ disease are most prominent in the 
deepest layers of the epiphyseal cartilage as this is the zone that depends most on the epiphyseal 
blood supply and therefore most affected by the ischaemic process. The superficial layers of the 
cartilage are nourished by the synovial fluid. The bone, also supplied by the vessels, becomes 
ischaemic. In the human specimens, all the bone from which the ossific nucleus was originally 
composed of was infarcted i.e., every hip biopsied showed histological evidence of at least one infarct 
throughout its extent. 
They found definite pathological evidence to link duration of symptoms and the incidence of 
double infarcts i.e. as the duration of symptoms increased, the number of specimens showing double 
infarcts also increased. Of the 23 hips with symptoms present for three months or less, 11 (48 per cent) 
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had pathological evidence of two infarcts. Of the 15 hips presenting at four to six months after the onset 
of symptoms, 10 (67 %) had evidence of two infarcts. 
The basal layer of cartilage though, continues to proliferate but the ossification is deficient. This 
leads to the formation of tongues of cartilage extending to the metaphysis as the bone growth in the 
adjoining areas continues normally. As the ossific nucleus again became revascularised, these features 
diagnostic of two infarcts ultimately disappeared and the bone remodeled. . 26 16  
 
I I I . i i i .b Blood supply to the femoral head 
 The need for a definite understanding of the vascular structures during growth is important as it 
is believed that Perthes’ disease is of vascular origin. First, the normal anatomy will be discussed and 
then the theories behind vascular and venous disease and how this is thought to cause Perthes’ 
disease will be elaborated. 
Langer, in 1876, showed by injection that vessels did, in fact, enter the developing femoral 
head through the ligamentum teres and that they were of fundamental importance to the epiphysis. He 
claimed that variations existed in the adult, but that these were secondary changes in which the vessels 
of the round ligament shrank to unimportance so that cervical vessels took over an almost exclusive 
supply of the head. Walmsley in 1915, examined 100 round ligaments but did not find a vessel of any 
size; he concluded that arteries of the ligament could convey no more than a small amount of blood. 
Furthermore, he demonstrated by injection that these vessels did not supply the ossific centre in two 
children aged two years and six years. Chandler and Kreuscher in 1932, examined 114 round 
ligaments, and made serial sections of six femoral heads, including two in which there had been 
fractures of the femoral neck. The subjects were adults, averaging 48 years. The ligament was absent 
in only one case and all others contained vessels. In four, the vessels were of pre-capillary size but in 
the others they carried a significant blood supply. In six specimens, Nordenson in 1938 suggested that 
these vessels, even although arteriosclerotic, were capable of hypertrophy, and that this capacity might 
explain why necrosis of the head was not more common. There was no difference in the blood supply 
between the males and females particularly at the age of maturation in the 46 specimens of the upper 
end of the femur that he studied. 27 
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Wolcott published an article in 1943 where he investigated the arterial pattern at various ages 
up to adolescence. He had previously made similar investigations in adults. His conclusions are 
important: 
1) In infants and children, the ossifying centre in the developing head of the femur receives its blood 
supply from capsular vessels which arise from the medial circumflex artery. 2) The ligamentum teres 
vessels do not enter the head of the femur in children, nor do they contribute to the nourishment of the 
growing femoral head, except for very small vessels at the site of implantation of the ligament into the 
foveolar area. 3) Anastomoses between vessels of the ligamentum teres, capsular arteries, and nutrient 
arteries of the shaft, do not take place until ossification of the femoral head is almost complete, by 
which time the vessels of the three systems unite by penetrating the thinned area of cartilage at the 
fovea. 4) The ligamentum teres circulation is closed, so far as the femoral head is concerned, until such 
anastomosis takes place.  
Retinacular arteries  
These vessels arise from the medial and lateral femoral circumflex arteries. There is, however, 
a brisk extracapsular anastomosis in the region of the trochanteric fossa to which the inferior gluteal, 
profunda femoris, obturator, and circumflex arteries contribute. The circumflex arteries lie superficial to 
the distal part of the fibrous capsule and they do not run within its substance. Branches of the arteries 
pierce the fibrous capsule near its lateral extremity and run medially along the neck of the femur, deep 
to the reflected cuff of synovial membrane. It is in this position that the vessels are associated with 
retinacular fibres. As a rule they are found in groups, although occasionally a few isolated and separate 
vessels may be observed. 
 There are three main groups of retinacular arteries - the posterosuperior, posteroinferior and 
anterior. The first two groups are branches of the medial femoral circumflex artery and they run along 
the upper and lower borders of the neck of the femur. If one looks at the head and neck of the right 
femur from the medial aspect, the posterosuperior vessels are found between eleven and two o’clock, 
and the posteroinferior vessels between five and seven o’clock. Although the groups may extend on to 
the front of the neck, they are usually posterior. These two groups are moderately large and quite 
consistent, the postero-superior group being usually the larger, and occasionally providing the 
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sole supply to the epiphysis. These are branches of the lateral epiphyseal vessels, which are branches 
of the distal part of the medial circumflex artery.  As the intermediate stage of vascular development of 
childhood is reached it is characterised by marked individual and racial variations. 27  
After age four, the cross connection between the metaphyseal and epiphyseal arteries 
begin to decrease. The points of entry of the lateral epiphysial arteries are close together in the outer 
segment of the head, and slightly posterior. A minute metaphyseal artery still reaches the epiphysis in 
its medial side, and a number of large arteries in the ligamentum teres end without any connection with 
the epiphysis. 
Some of the infantile metaphyseal vessels may still remain. Apparently, this double supply is an 
arrangement that protects the nourishment of the epiphysis during the transient intermediate period 
which extends from four to seven years. More commonly, the distribution of the metaphyseal arteries at 
about six years of age is like that of the adolescent, when they have finally disappeared, but the 
infantile absence of blood flow from the ligamentum teres still persists. The picture opposite is a good 
example of this intermediate vascular pattern. In the pre-adolescent period i.e. the age of seven 
upwards, the penetration of vessels from the ligamentum teres appears to be increasingly frequent, and 
at nine or 10, the pre-adolescent type of epiphyseal blood supply seems definitely established, even if 
sometimes the participation of the medial epiphyseal arteries does not seem as great as in adult life. 
The growth plate is an isolating barrier raised between the femoral epiphysis and the rest of the bone, 
and this barrier persists till epiphyseal fusion is complete. 
 
Foveolar artery/ Artery of the ligamentum teres  
In children up to the age of 13 years, in eight specimens out of 24, the artery penetrated the 
fovea and supplied the deep cartilage of the head or the ossific centre. The vessels were very small 
and varied from one to five in number. In the other 16 specimens, the vessels spread out over the 
surface of the fovea like the fingers of an outstretched hand, obviously being concerned solely with 
supply of the fibrous tissue of the ligament and its attachment to the cartilaginous head. 
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Relative importance of the retinacular and foveolar vessels in children 
The cartilaginous head and the ossific centre are supplied almost entirely from retinacular 
vessels, while in a few specimens the foveolar vessels contribute. In the series reported, foveolar 
vessels were of importance only in a minority of cases. If this view is accepted, the site of obstructive 
vascular lesions causing avascular necrosis must be located in the retinacular group of vessels. The 
foveolar supply may afford additional protection to the ossific centre. The epiphysis in the child is more 
dependent upon retinacular vessels than is the corresponding area of bone in the adult, thus explaining 
the greater frequency of avascular necrosis in children 
Perthes’ disease- If injury is the cause of Perthes’ disease, vulnerability of the epiphysis to 
infarction will be greatest when the blood supply is derived largely from the posterosuperior vessels. In 
other words, multiple sources of vascular supply provide a safeguard to the nutrition of the femoral 
epiphysis; in contrast, concentration of the vascular supply to one group of vessels constitutes a 
potential danger. Tucker believed that the posterosuperior group of vessels was susceptible to pressure 
from the acetabular lip and its labrum in positions of forced abduction and external rotation of the hip, 
and that it is individuals with this pattern of vascular supply who were most prone to Perthes’ disease. 27 
This was confirmed in children with Perthes’ disease by Atsumi et al who did super selective 
angiography in 28 hips (25 children) and noted the disruption of the lateral epiphyseal arteries in 19 of 
the 28 hips (68%). This decrease in blood flow was more acute in the internally rotated and abducted 
position. Features of revascularization were obvious by angiography even at stage one disease. 28 
 
I I I . i i i .c Normal clott ing mechanism and basic pathology of thrombosis  
 The coagulation cascade of secondary hemostasis has two pathways, the Contact Activation 
pathway (formerly known as the Intrinsic Pathway) and the Tissue Factor pathway (formerly known as 
the Extrinsic pathway) that lead to fibrin formation. Figure ## It was previously thought that the 
coagulation cascade consisted of two pathways of equal importance joined to a common pathway. It is 
now known that the primary pathway for the initiation of blood coagulation is the Tissue Factor pathway. 
The pathways are a series of reactions, in which an enzyme and its co-factor are activated to become 
active components that then catalyze the next reaction in the cascade. 
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The Virchow’s Triad of blood abnormalities, vessel wall abnormalities and flow abnormalities, 
as causes for thrombosis, still holds good. This theory states that thrombosis in vessels is multifactorial 
and the three things that influence this are  blood composition- any abnormalities causing an increase 
in thrombotic tendency will fall under this category, the vessel wall – which if damaged can initiate the 
clotting cascade, and the flow  i.e. if there is turbulence there is a higher chance of clot formation. 
The causes for an increased risk for thrombosis can be classified under either congenital or 
acquired causes. Congenital causes include Antithrombin deficiency, Protein C and Protein S 
deficiencies, The Factor V Leiden mutation, and MTFHR and Prothrombin variants.  There is good 
evidence to show that factor elevations that do cause thrombosis are also clustered in families ( such 
as FVIII) but the mode of inheritance has not been identified. Acquired causes of thrombosis include 
malignancy, PNH, anti-phospholipid antibody syndrome, smoking, obesity, OCPs, immobilization, 
pregnancy, dysfibrinogenemia etc. 
The most often identified sites for venous thrombosis in the western population were the deep 
veins of the lower limb and pelvis. The causes for deep vein thrombosis (DVT) in the western 
population have been investigated and the general profile quite well documented. Taking this as a 
starting point – i.e. assuming that the same process was at work in the femoral head as well –clotting 
abnormalities were looked for in Perthes’ disease and first reported in the mid nineties. Each of the 
factors that were implicated will be discussed separately under subheadings. 
 In India, the incidence of DVT has been recorded in the King Edward Memorial Hospital 
in Bombay and in C.M.C., Vellore. The rates of DVT measured in Vellore were 7/100,000 and the rates 
of pulmonary embolism were about 6/100,000.  In K.E.M. Hospital, the rates were lower and have been 
quoted as 3.7/100,000 for DVT. These values are about 10 times lower than in the West where rates of 
DVT are as high as 48/100,000 per year and the rates of Pulmonary embolism as high as 23/100,0000 
as reported by Anderson et al. 29      
In the West, Protein C, Protein S, antithrombin (AT), the factor V Leiden and prothrombin 
mutations were present in about one third of unselected patients with venous thromboembolism.  In 
addition to these inherited thrombophilic defects, elevated plasma levels of factor VIIIc have been 
suggested to be important in the pathogenesis of venous (and recurrent) thromboembolism. The Factor 
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V Leiden mutation was reported to be the commonest abnormality in DVT in the western population 
with rates of prevalence between five to 30%. The data from our clinical pathology lab show that the 
incidence of this abnormality is much lower here than in the western population. 30 31The incidence of 
clotting factor abnormalities in Perthes’ disease have been reported only recently, the first report being 
in 1994. These studies showed low levels of protein C, protein S and hypofibrinolysis as causes for 
clotting abnormalities.,1,2,3,An elevated level of homocysteine is an independent risk factor for 
cardiovascular diseases and is associated with other complex disorders. Homocysteine levels can be 
elevated due to dietary and/or genetic factors. The role of Homosysteine levels in Perthes’ has not been 
examined by most studies. 32, 33, 34, 35 
 
FACTOR VIII LEVELS 
High levels of FVIII were recently determined to be a possible independent major risk factor for 
deep-vein thrombosis. Whether high FVIII levels after previous thromboembolism are acquired or 
hereditary is still open to debate. The normal values of Factor VIII is considered to be 1000 IU and 
concentrations are reported as a percentage; a FVIII concentration of 1000 IU/L corresponds to 100%. 
Genetic defects that promote high FVIII levels have not been found so far. 
One study showed that Factor VIII levels in patients with unexplained thrombosis had relatives 
with high levels of thrombosis- suggesting that the levels of FVIII are high in some families. 36  Others 
have demonstrated that a high FVIII level is persistent over time and is a risk factor for thrombosis, 
independent of  the acute phase state. However, it is unknown whether there is a critical cut-off value 
above which the risk increases or if risk increases continuously with increasing levels of FVIII.  Patients 
with FVIII levels of ≥ 150 IU/dL had an adjusted odds ratio for risk for DVT of 4.8 (95% CI, 2.3 to 10.0) 
compared with patients with FVIII levels ≤ 100 IU/dL. Hence, high FVIII concentrations represent a risk 
for thrombosis similar to those of deficiencies of inhibitors like proteins C and S and APC resistance. 37, 
38 
A population-based patient-control study was done in which 301 consecutive patients younger 
than 70 with a first, objectively diagnosed episode of venous thrombosis and without an underlying 
malignant disorder were compared with 301 healthy controls matched for age and sex. In this study by 
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Schambeck et al, for individuals with factor VIII concentrations higher than 1500 IU/L, the risk of 
thrombosis was six times higher than that for subjects in the reference category (<1000 IU/L). This high-
risk stratum comprised no less than 25% of the patients and 11% of the controls. The reported 
associations did not change with adjustment for body-mass index, diabetes mellitus, and smoking 
status. The prevalence of factor VIII levels above 1500 IU/L was also high among the healthy control 
subjects (11%). 36 
Koster et al felt that raised factor VIII, similarly to protein C deficiency and activated protein C 
resistance was not in itself sufficient to cause thrombosis. However, once the other required causal 
factors were present, high factor VIII concentrations presented a strong thrombosis risk, which was 
about as high as the relative risk of thrombosis for deficiencies of the major anticoagulants and a poor 
response to activated protein C.39 
In a study by Tirado et al,  patients with thrombosis showed higher FVIII levels than the controls 
(200.1± 75.9% versus 151.9± 57.7%, p<0.0001).  When FVIII levels were analyzed among different 
blood groups, significantly higher levels were found in the patients than in the controls. The risk for 
thrombosis attributed to FVIII levels higher than the 90th percentile was OR 2.9..They also  observed 
that the increase in risk due to FVIII levels was continuous, that is, patients with higher levels had 
higher risks.40 
Inherited and acquired thrombophilia are also associated with recurrent pregnancy loss. 
Dossenbach-Glanninger et al evaluated the relation between recurrent early pregnancy loss and levels 
of FVIII in patients with multiple pregnancy losses and found that there was a significantly higher level 
of FVIII in those patients with recurrent pregnancy loss with a relative risk of 3.9 for those patients who  
had a level of factor > 156% ( 95th percentile). 41 
In a case-control study performed by Kupferminc et al, 42 about 65% of vascular complications 
in pregnancy were associated with acquired or genetic thrombophilia. Recently, a metaanalysis of 13 
studies confirmed the association of Factor V Leiden mutation i.e. a prothrombotic risk factor with early 
pregnancy loss. 43  This lends support to the claim that FVIII, similar to other prothrombotic factors, is 
an independent risk factor for thrombosis. In India, a study done by Shah Sudeep et al in patients with 
 28
portal vein thrombosis revealed that about 25%  (6/26) of patients had elevated FVIII levels – showing 
that in the Indian population, Factor VIII may be a significant cause of thrombosis.44 
There has been debate as to whether the rise in factor VIII levels is a primary elevation or an 
acute phase reactant that gets elevated in response to the thrombosis per se. The argument that the 
thrombotic event itself may cause an inflammation and result in the elevation of factor VIII levels and 
fibrinogen has been disproved by the study by Kraaijenhagen et al.  45 They measured the levels of 
CRP( an acute phase reactant marker) and fibrinogen and factor VIII and showed that there was no 
significant association between these.  This study has supported the reasoning that elevation of FVIII is 
independent of an acute phase reaction. They found that an elevated factor VIII plasma concentration 
was a prevalent, independent and strong risk factor for venous thromboembolism. Increased factor VIII 
levels (above >175 IU/dl) may be found in approximately one quarter of unselected patients with 
symptomatic venous thromboembolism, which is in agreement with earlier observations. 
For each 10 IU/dl increase of factor VIIIc, the risk for venous thromboembolism in all patients 
increased by approximately 17% and in recurrent thromboembolism by 24%.46 O’Donell et al followed 
up a cohort of patients with elevated FVIII levels who had DVT and found that 94% continued to have 
an elevated FVIII:C level throughout the period of follow up (median 8 months; range 3 to 39 months), 
with no significant difference between the FVIII:C levels determined at first estimation and those 
obtained during follow up (p = 0.58). Only 18% of these patients had an elevation of an acute phase 
reactant - again supporting the hypothesis that the level of FVIII is not an acute phase reactant. 30, 
Protein C 
Protein C is a circulating glycoprotein that is a part of the negative feedback system of blood 
clotting. A low level of Protein C increases the tendency to clot i.e. thrombophilia. The levels of protein 
C are known to be lower in children than in adults. 47 
This deficiency of protein C can be acquired or inherited. The population frequency of Protein C 
levels in India has not been reported. Though the deficiency of Protein C for the Indian population with 
thrombophilic events has not been reported, data from our institution shows an incidence of 9% in those 
with DVT (2005 – 2006 unpublished data of 606 patients).  
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Protein C circulates in an inactive proenzyme form normally and is activated by thrombin to 
become functional as an anticoagulant. Once activated, it is known as activated protein C (APC) and 
begins to deactivate factors V and VIII and also stimulates fibrinolysis as well as preventing formation of 
thrombin. 
Resistance to APC (APCR) in an activated PTT assay is a recently described mechanism for 
thrombophilia. (1). The most well-known of the causes for APCR is the Factor V Leiden Mutation that is 
characterised by the substitution of the arginine residue at 506 to glutamine. 48,49,50,51,52 
The incidence of  familial Protein C and protein S deficiencies are rare  in the western 
population with a heterozygote prevalence of  one in 16,000 to 20,000 to one in 200 to 300.53 In 
patients with thrombophlebitis the incidence is less than 5%. As the incidence of Perthes’ disease in 
India varies from  0.4 per 100,000 to 4.4 per 100,000 in Vellore per year as reported by Joseph et al . 
17, by chance alone  the estimated likelihood of  a child having LCPD and a concurrent  deficiency of  
Protein C would be less than 1 in five hundred.                  
In 1994, Glueck et al 3 published their first study showing five of eight patients with a 
thrombophilic tendency of whom three had a protein C deficiency. Glueck et al studied 44 unselected 
children with Perthes’ disease of which 33 ( 75 %) had coagulation abnormalities and 19 of these 33 
had a protein C deficiency. In 11 of the 19 children who had a low protein C level, at least one of the 
first-degree relatives of had a low protein-C level as well; all of these low levels represented previously 
undiagnosed familial protein C deficiency. These 11 children who had familial protein C deficiency were 
more likely to have early onset of Legg-Perthes’ disease (at or before the age of 5) than the eleven 
children who were completely normal (chi-square = 6.6; p = 0.01). 1.  
Manucci and Vigano have reported that the levels of protein C may be reduced by either 
infection or injury-53. This will definitely influence the levels of protein C measured as most of the 
studies on clotting abnormalities in Perthes’ disease were done on a retrospective basis and most, long 
after the onset of Perthes’ disease. Transiently low levels of Protein C secondary to an infection will 
therefore be missed. 
Eldridge et al conducted a case-control study among 57 patients with Legg-Perthes’ disease 
and measured protein C and protein S and resistance to activated protein C (APC-R) from plasma. 
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They observed a statistically significant increased risk of Legg-Perthes’ disease with decreasing levels 
of protein C. The factor V gene (contributing to APCR) defect was present in five (9%) of 55 cases and 
three (5%) of 56 controls (odds ratio 1.8, 95% confidence interval: 0.4 –7.7), but the mean level on the 
APC-R plasma test was similar for cases and controls. Nine cases and one control had two low normal 
or low test results (odds ratio 13.0, 95% confidence interval: 2.2–75). Their results support the belief 
that abnormalities of the coagulation system leading to a thrombophilic state play a role in Legg-
Perthes’ disease.54 This was a retrospective study and the same problems with respect to testing of 
values sometimes long after the onset and resolution of the disease hold good here as well.  
Protein S 
Glueck et al studied 44 unselected children with Perthes’ disease of whom he found of which 
four had protein-S deficiency. At least one first-degree relative of one of the four children who had a low 
protein-S level, had a low protein-S level and previously undiagnosed familial protein S deficiency1 
Eldridge et al conducted a case-control study among 57 patients with Legg-Perthes’ disease 
observed a nearly significant increased risk with decreasing levels of protein S. Their results lend 
support to the belief that abnormalities of the coagulation system leading to a thrombophilic state play a 
role in Legg-Perthes’ disease. 54 
 
Factor V Leiden mutation and Activated protein C resistance 
In their study of 44 children with Perthes’ disease, Glueck et al reported that three children had 
hypofibrinolysis (a reduced ability to lyse clots) and seven children had a high level (0.25 gram per litre 
or more) of lipoprotein(a), a thrombogenic, atherogenic lipoprotein associated with osteonecrosis in 
adults. 1  
Glueck et al in 1997 investigated 64 patients with Perthes’ disease in whom they examined the 
factor V Leiden mutation and found that 8 out of 64 children had the mutant Factor V gene as opposed 
to one of 101 normal controls. There was evidence of familial involvement with this trait.55, 
In the 47 patients with Perthes’ disease included in the study by Szepesek et al, 10.6% had the 
Factor V Leiden mutation and of these 4 were homozygous for FVL. All these patients had Caterall IV 
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disease and head at risk signs. This is suggestive that severe disease is associated with thrombotic 
tendencies. 10, 
Balasa et al in 2004 did a prospective study on 72 children with 197 controls and found that the 
FVL mutation was more common in the patients (8 of 72) that in the controls (7/197). After making 
adjustments for a false discovery rate they found a significant difference between the groups. The odds 
ratio for developing Perthes’ disease was 3.39. They  felt that the FVL mutation was associated with 
Perthes’ disease and this may reflect causality. 2 
Arruda et al carried out an investigation of FVL, the transition 20210 G->A in the prothrombin 
gene, and also the homozygosity for the 677C->T transition in the methylenetetrahydrofolate reductase 
gene (MTHFR). The investigation was carried out among 61 Brazilian children with LCPD, who were 
compared with 296 individuals from the general population. The prevalence of the factor V Leiden 
mutation was higher in LCPD patients than in the controls (4.9 vs. 0.7%; p = 0.03). However, no patient 
had the prothrombin gene variant, and no difference was found between patients and controls when 
homozygosity for MTHFR-T (3.2 vs. 2.6%; p = 0.64) was determined. They felt that the heterozygosity 
for factor V Leiden was the only inherited risk factor associated with the development of LCPD in this 
subgroup of Brazilian children. 56. 
 
ANTIPHOSPHOLIPID ANTIBODY 
Anticardiolipin antibodies, lupus anticoagulant, and antibodies causing false positive tests for 
syphilis belong to a family of autoantibodies called antiphospholipid antibodies, which are active against 
negatively charged phospholipids and are clinically manifested by an increased tendency for 
thromboembolic events. Although it is well established that their presence is associated with 
thrombocytopenia, midpregnancy recurrent fetal loss, stroke, and cardiac valvular disease, the main 
associated feature is venous and arterial thrombosis. Vessels of all sizes may be involved, including the 
aortic arch, pulmonary and cerebral vessels, coronary arteries, retinal arteries, peripheral arteries, and 
smaller skin vessels. The combination of recurrent thrombosis and antiphospholipid antibodies in 
patients without features of systemic lupus erythematosus is called primary antiphospholipid syndrome. 
The syndrome is secondary if the patient also has systemic lupus erythematosus or a lupuslike disease.  
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Balasa et al in 2004 did a prospective study on 72 children with 197 controls and found that 19 
of 72 patients as compared with 22 of 197 patients had elevated anticardiolipin antibodies. After 
controlling for the false discovery rate, they found that there was a significant difference between the 
two groups. 2 
Korompilias et al studied the prevalence of anticardiolipin antibodies, in 40 consecutive patients 
(25 men and 15 women) with nontraumatic osteonecrosis of the hip, which have been associated with 
thrombotic phenomena. Their ages ranged from 19 to 56 years (average, 34.3 years). Anticardiolipin 
antibodies were present in 37.5% (15 of 40) of the tested patients, a significantly higher rate than is 
seen in healthy subjects, of whom only one of 100 had low titer anticardiolipin antibodies (1%). Six of 40 
patients tested positive for immunoglobulin M alone, and six of 40 patients tested positive for 
immunoglobulin A alone. Three of 40 patients tested positive for immunoglobulin M and immunoglobulin 
A isotype. They reported that the results of their study indicated an increased incidence of 
anticardiolipin antibodies in patients with nontraumatic osteonecrosis of the femoral head, probably 
reflecting that anticardiolipin antibodies play a role in the pathogenesis of bone necrosis by 
predisposing to thrombotic phenomena. 57 Chan et al have reported that APLA is associated with VTE 
in children with systemic lupus erythematosus.50, 
Homocysteine 
Homocysteine, a sulphur-containing amino acid, is an intermediate formed during the 
catabolism of the essential dietary amino acid methionine as a by-product of biological methylation 
reactions.  Approximately 80% of plasma homocysteine is protein bound. Only a small amount exists as 
free reduced homocysteine, as the majority of the unbound portion is oxidized to form diamers 
(homocystine) or combined with cysteine to form mixed disulphides. Hyperhomocysteinemia (HHcy) is 
an independent risk factor for cardiovascular disease, including ischemic heart disease, stroke, and 
peripheral vascular disease. Mutations in the enzymes responsible for homocysteine metabolism, 
particularly cystathionine b-synthase (CBS) or 5,10-Methylenetetrahydrofolate reductase (MTHFR), 
result in severe forms of HHcy. The reaction with MTHF occurs in all tissues and is vitamin B12–
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dependent, whereas the reaction with betaine is confined mainly to the liver and is vitamin B12–
independent.  
 Additionally, nutritional deficiencies of vitamin B cofactors required for homocysteine 
metabolism, including folic acid, vitamin B6 (pyridoxal phosphate), and/or B12 (methylcobalamin), can 
induce HHcy. Studies using animal models of genetic and diet-induced HHcy have recently 
demonstrated a causal relationship between HHcy, endothelial dysfunction, and accelerated 
atherosclerosis. Dietary enrichment in B vitamins attenuates these adverse effects ofHHcy.  35  
 The study by Jakubowski supports a hypothesis that protein N-homocysteinylation and resulting 
protein damage cause homocysteine toxicity to human cells, especially to vascular endothelium. The 
homocysteine theory of atherosclerosis arose from the observation that diseases such as homozygous 
homocystinuria, which are characterized by severe hyperhomocysteinaemia (>0·1 mmol . l_1), are 
associated with premature vascular disease. 
 Jakubowski suggests that homocysteine is atherogenic in places where arteries branch out as 
these branches have a high local concentration of NO which precipitated the incorporation of 
homocysteine into proteins and causes vascular endothelial damage. This is accentuated in patients 
where the levels of homocysteine are high due to different reasons. 32 
 The epidemiological evidence for the homocysteine theory of atherosclerosis is based largely 
upon pathophysiological homocysteine concentrations of 0·01– 0·03 mmol . Patients with homozygous 
homocysteinuria have plasma concentrations of upto 0·4 mmol . However, many of the in vitro studies 
described above demonstrated adverse effects of homocysteine at concentrations of 1–10 mmol. 
making the pathophysiological significance of these experiments difficult to interpret. Despite these 
criticisms, there are several plausible mechanisms for homocysteine-induced atherogenesis and 
thrombosis: such as 1. Endothelial cellular and DNA damage 2.  Reduced activity of glutathione 
peroxidase 3. Stimulation of procoagulant and impairment of anticoagulant and fibrinolytic pathways 4.  
Mitogenic effect on smooth muscle proliferation 5. Promotion of endothelial–leukocyte interactions. 34 
Although venous thromboembolism accounts for 50% of the vascular complications of 
homocystinuria, the link between less severe hyperhomocysteinemia and venous thromboembolic 
disease was overlooked until recently. Recurrent episodes of thromboembolism, events that occur at an 
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early age, thrombosis after trivial provocation, and thrombosis at unusual sites are all features which 
should heighten the suspicion that an inherited metabolic abnormality is playing an etiologic role. Most 
studies done on thrombophilia and Perthes’ disease have not examined the relation between the 
disease and the MTFHR gene which results in elevated homocysteine levels. 35 Only Arruda et al have 
examined the incidence of the MTFHR gene and did not find any significant association with the at risk 
population. 56 
  
ANTITHROMBIN III 
 Rosendaal mentions that the first report of a family with an identified hereditary tendency to 
thrombosis (a deficiency of antithrombin, previously known as antithrombin III) was made by Egeberg in 
1965. Since then, it has been described as an independent risk factor for thrombosis and therefore was 
examined in our study as a part of the work up for thrombosis.58 
  
Fibrinogen 
 Koster et al  from the LETS study group reported a positive, level-related, association between 
plasma fibrinogen level (as measured with the Claus assay) and risk of venous thrombosis. This 
conclusion was based on the analysis of the first 199 patients and 199 controls of the Leiden 
thrombophilia study (LETS). Later the analysis was extended to all the 474 patients and controls of the 
LETS.  Subjects with plasma fibrinogen above the 95th percentile of the distribution measured in the 
control subjects, had a 2.8 fold increased risk of a first deep vein thrombosis. This risk was found to be 
equal in men and women, and even higher (OR 4.2) in subjects older than 45 years. Adjustment for 
other risk factors (prothrombin, FVIII, FIX, FXI, FV Leiden, PT20210A) and C-reactive protein reduced 
the OR to 1.5 (95% CI  of  0.8- 3.0). This finding indicates that the effect of elevated fibrinogen levels on 
thrombotic risk might be very small, even in subjects older than 45 years. 59 
 
MULTICAUSAL DISEASE 
 Thrombosis manifests itself as a multicausal disease most clearly in children. In the rare event 
of thrombosis in children, several acquired and genetic risk factors are usually present simultaneously. 
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Not only is it rare to find children with thrombosis without any risk factor, but many have three or four 
risk factors. In 25–30% of children with thrombosis, deficiencies of protein C, protein S, or antithrombin 
have been reported, but thrombosis did not develop until other risk factors were present, such as 
intravenous lines or major illness.50 Thrombosis is also a multicausal disease in adults since many risk 
factors are common in the general population, such as factor V Leiden, prothrombin 20210A, 
high concentrations of factor VIII, and hyperhomocysteinaemia, which frequently occur together in one 
individual. The acquired risk factors, such as pregnancy, puerperium, use of oral contraceptives, and 
immobilization also affect many people, and so a combination of risk factors in one person is common. 
Indeed, multiple risk factors often are a prerequisite for thrombosis to develop. Since some of the 
recently discovered genetic abnormalities are common, as are several acquired risk factors, the joint 
effects of such factors on the risk of thrombosis warrants investigation. Clear indications of synergistic 
effects come from studies in thrombophilic families, where high risks were found in pregnancy and 
puerperium, and during use of oral contraceptives for women with deficiencies of protein C, protein S, 
or antithrombin. In several series of unselected women with thombosis during pregnancy, factor V 
Leiden was more common than in the general population. The frequency of factor V Leiden among 
these women varied widely between studies, from 8% in Scotland to 50–60% in Sweden, which partly 
reflects geographical differences in the population prevalence of factor V Leiden. These data suggest 
that a substantial part of pregnancy-related thrombosis results from concomitant abnormalities in the 
haemostatic system. Among unselected patients, a synergistic effect has been shown for factor V 
Leiden and use of oral contraceptives: the estimated baseline risk of thrombosis for non-carriers who do 
not use oral contraceptives was 0·8 per 10,000 people per year. The annual risk for women with factor 
V Leiden who did not use oral contraceptives was 5·7 per 10,000 people (relative risk 6·9), that for 
women who used oral contraceptives but did not carry factor V Leiden was 3·0 per 10 000 women 
(relative risk 3·7), and that for women with factor V Leiden who used oral contraceptives was 28·5 per 
10 000 people (relative risk 34·7). For cerebral sinus thrombosis, increased risk of thrombosis has been 
reported for thrombophilic defects. 60 
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III.iii.b Vascular theory – interruption of  femoral arterial supply  or venous drainage: 
In the hip joint, there are two unusual features that place the joint at risk when subjected to 
injury, namely, the fact that the capsule is virtually incapable of being distended and because, as 
discussed in the section on anatomy, due to the unique blood supply to the hip joint, the vessels can 
also be affected.  
Kemp, in 1981, did an experimental study on dogs where he suggested that the degree of 
epiphyseal involvement may be related to the intensity of the intracapsular tamponade. The reason why 
he chose dogs to do this study was that there is a close parallel between the developing blood supply in 
the child and in the puppy and that there is a progressive incorporation of the blood vessels into  fibro-
osseous canals in the femoral neck as maturation takes place. In some breeds of puppies resistant to 
Perthes’ disease, the venous tamponade was present only with an intracapsular pressure in excess of 
120 mm Hg (the systolic pressure of the experimental animal). In contrast to the response of the 
resistant animals, the marrow pressure in the susceptible poodles showed an immediate response to 
tamponade, responding sensitively to the progressive elevation of intracapsular pressure and this was 
thought to be due to the fact that the draining veins were intracapsular. He felt that this evidence 
obtained from experiments on dogs suggested that transient venous occlusion could produce coxa 
plana. 61 
In 1986, Kemp performed intracapsular tamponade of the hip joint under anesthesia in rabbits 
and puppies by the injection of wax that was liquid at body temperature to simulate an effusion. The 
hips of these animals when examined microscopically showed features consistent with Perthes’ disease 
and this study supported venous occlusion as a possible etiology for Perthes’ disease. He felt that if the 
disease was to occur in a particular hip, then two factors were required- first, an intrinsic factor, which 
he felt was the delayed skeletal growth and the second, an effusion in a susceptible joint. He felt that in 
a susceptible hip joint, an effusion could produce an obstruction of the venous return, because the hip 
capsule is incapable of distension and this could make the epiphysis (and possibly the associated 
metaphysis) vulnerable to transient anoxia. 62 Chung demonstrated that the anterior vessels had much 
less anastomoses than the posterior vessels and these anastomoses were more often incomplete in 
boys and attributed the higher incidence in boys to this phenomenon. There was also an attenuation of 
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the extracapsular network in children aged 3- 10 years – a normal process that occurs during growth. 
This may be why Perthes’ disease occurs more often in this age group. 63 Most of the work done on the 
blood supply of the hip, both in children and in adults, was influenced by. Prof Joseph Trueta.64, 65. 
Deficient venous drainage as the cause for vascular insult was suggested by Heikkenen et al. They 
proved that poor venous drainage was a prognosticator for severity of disease. 66. An animal study in by 
Liu and Ho revealed a higher venous pressure in femoral heads of children who were affected by 
Perthes’ and suggested that this venous hypertension may be the precipitating factor for thrombosis. 
They then did a follow up with a study on dogs and were able to demonstrate this experimentally. 67 
 
Harrison and Burwell, in 1981 wrote that the concept of extraepiphyseal vascular interference 
was attractive, but was inconsistent with clinical facts such as the fact that the vascular vulnerability of 
the epiphysis was limited to the interval between the third and eighth years. They felt that the 
tamponade ought to be painful due to the avascualrity but the onset of Perthes’ disease is usually not 
marked with an episode of acute pain and hip spasm.  Bilateral Perthes’ disease occurred in over 10% 
of patients, the disease affected four boys to one girl and not rarely more than one child of a family; in a  
number of families, more than one generation were affected.  Though the former points still hold good, 
the rest can be reevaluated in the light of the fact that thrombosis could cause occlusion in the 
susceptible hip and that it was not yet discovered then. However, they also said that  Perthes’ disease 
could no longer be considered a hip disease in an otherwise normal child, but rather a focal expression 
of a general disorder of skeletal growth. A hypothesis based on these observations is that Perthes’ 
disease is a force-oriented hip lesion based upon a constitutional defect which affects growing bones. 
The infarction in Perthes’ disease was self-perpetuating and healing was proportionately slow. 68  
 
Sanchis et al proposed the double infarction theory where they experimentally infarcted the 
femoral capital epiphyses of puppies. They were unable to demonstrate the typical histological picture 
of Perthes’ disease with only a single infarction. After repeating the infarction again they were able to 
show a more characteristic picture of Perthes’ disease. 69 Clinical correlation for this theory is provided 
by reports of recurrent Perthes’ disease in children by Katz as well as Martinez and Weinstein.70,71. 
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That the vascularity of the femoral epiphysis was embarrassed is beyond question; whether it 
was arterial or venous remained.  
 
I I I . i i .c  Perthes’ disease as a systemic disorder 
There are suggestions by authors that Perthes’ disease should be called Perthes’ syndrome as 
there are often multiple sites that show the same histological and radiological features of avascular 
insults. Smith and Nevelos in 1980, described osteochondritis occurring at multiple sites in Perthes’ 
disease that was especially prominent in the navicular.  72. Bilateral hip disease was reported to be 
about 11.3% by Wynne-Davies and Gormley in 310 patients. They felt that it was unlikely that there 
were any genetic factors in the great majority of cases. Bilateral hip involvement was noted in only 6% 
of patients by Chacko et al, which is less than that reported elsewhere. 24  Pillai et al, in 2005, reported 
that in 40 children with Perthes’ disease from South West Scotland, there was bilateral involvement of 
the hip in 7.7%. 19 
Harrison and Blakemore reported 48% of contralateral hips having contour abnormalities with only 
10% of the control series having the same abnormality (irregularities of the surface and flattening or 
dimpling of the femoral head. 73. 
Kitoh et al studied radiographs of 125 children (105 boys, 20 girls) with unilateral Legg-Calvé-
Perthes’ disease to examine the epiphyseal development of the femoral head in the contralateral 
(unaffected) hip. The epiphyseal height (EH) and width (EW) of the unaffected hip were measured on 
the initial anteroposterior pelvic radiograph. In 87.2%, the EH was below the normal for children in the 
same age group. This indicates that there may be abnormal development of the femoral head in this 
disease. 74. 
This is further evidence of the fact that Perthes’ disease is a systemic disease. Burwell et al felt 
that the skeletal abnormalities they found in their patients could be explained by one of two factors - 
possible local disorder of allometric growth at the hip and a general disorder of skeletal maturation and 
felt that these two factors acting together might produce Perthes’ disease. 75. 
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Endocrine abnormalities  
Some aspects of endocrine function have been evaluated in affected children. According to the 
study by Burwell et al hypothyroidism, growth hormone, follicle stimulating hormone, luteinising 
hormone and 17- ketosteroid abnormalities were not significantly associated with Perthes’ disease. 
They have mentioned though that some patients with severe growth limitation and Perthes’ disease 
were investigated and about 25% of these children were found to have hormonal abnormalities. 
They found that in their population there was a tendency to low levels of growth hormone and raised 
levels of somatomedin in some children with Perthes’ disease. 75  Rayner  et al noting the frequent 
association of short stature and retardation of skeletal maturation in Perthes’ disease studied a group of 
18 prepubertal boys, aged five to 11 years, who had features of growth retardation. Their serum growth 
hormone (Se GH) response to insulin-induced hypoglycemia was significantly reduced, compared with 
a control group of short boys. They also demonstrated a tendency to elevated levels of somatomedin 
activity, measured by chick cartilage bioassay. Thyroid function was normal. They attributed these 
findings to a probable defect in the pituitary-somatomedin-target tissue axis in Perthes’ disease. 76. 
 Burwell et al in 1986 examined the Somatomedin C ( IGF1) axis in 67 boys with Perthes’ 
disease and 43 control boys aged three to 11 years using a bioassay based on the principle that 
somatomedins stimulate the synthesis of both DNA and proteoglycans in porcine costal cartilage. In 
control boys, the serum somatomedin activity increased with age, which is consistent with previous 
reports for normal children. In affected boys, the normal increase in serum somatomedin activity with 
age did not occur. The children with Perthes’ disease had higher levels of somatomedin activity 
between three to five years but not at six to 11 years of age. These findings support the hypothesis that 
some children with Perthes’ disease have an abnormality of the  growth hormone-dependent 
somatomedins. The serum findings together with those of both skeletal age delay and impaired skeletal 
growth distally in the limbs are consistent with the view that the general disorder of some children with 
Perthes’ disease results from an imbalance in pituitary axis. 77. 
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Perthes’ disease and genetic inheritance 
As mentioned in the history, familial history has been noted and the cause for this has been 
debated for nearly a century now. That Perthes’ disease had a familial tendency was reemphasized 
since the 1980’s and has been given mention by Hall DJ, O’Sullivan et al and Wynne-Davies. 78, 79, 80 
However, the genetic basis of this was not investigated then and no cause was found for the familial 
incidence.  
Pillai et al in 2005 reported that in 40 children with Perthes’ disease from South West Scotland 
there were three patients who had either a parent or a sibling affected with Perthes’. 19 
The frequency of Perthes’ disease among near relatives was extremely low and it rarely 
involved both identical twins. The proportions of affected second and third-degree relatives dropped 
immediately to the probable population frequency (about 3 per 1000 males). The reason why males are 
more commonly affected is still not known-  it would be expected that girls would have a higher 
incidence than noted of Perthes’ disease if it was a genetic abnormality. 25 
 Hall DJ et al reported on the family data from a series of 87 boys and 58 girls with Perthes’ 
disease combined with those of another study by Gray et al (223 boys and 44 girls).  Proportions of 
first, second, and third degree relatives affected were recorded separately for each sex of index cases 
and each sex of relatives. Comparison of the incidence of Perthes’ disease in relatives with that in the 
general population of the same sex revealed features of multifactorial inheritance, and a gradient of 
35:4.4:1 from first:second:third degree relatives to the general population. They argued that the 
concentration of cases in certain families was not inconsistent with multifactorial inheritance. 79. 
 It is not always possible to know whether bilateral Perthes’ disease with a strong family history 
that was reported in previous studies was merely one of the many skeletal dysplasias involving the hip 
joints i.e. multiple epiphyseal dysplasia or spondylo-epiphysial dysplasias. 
 Glueck et al have reported a positive family history in their study and also reported incidence of 
adult AVN and thrombotic episodes as being more common in families of patients affected with Perthes’ 
disease. 1  
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Socio-Economic status 
 Environmental factors were thought to play a part in the aetiology and were investigated.  
There are studies showing that there is an increased incidence of Perthes’ disease in the urban 
population in Liverpool, as well as, an association with a lower socio-economic status and since the 
urban population is from the inner cities, this could be linked. In the study by Barker and Hall, there was 
a distinct increase of incidence in the inner city wards (the slums) with - 4 per 100,000 in Social Class l 
to 26 per 100,000 in Social Class 5. 21 A highly significant excess of patients from low income group 
families (social classes IV and V) was found in the study done by Wynne-Davies and Gormley in 
Edinburgh and Glasgow City. The “expected” proportion of low income families in this population was 
approximately 28 per cent, whereas the “observed” proportion among the Perthes’ families was 43 per 
cent. A high significant proportion of these children came from low-income families 25  (43% as opposed 
to 28% in the normal population). 
It was found that the incidence was high in children who were born late in the family. The 
siblings who were born later were more likely to have had the disease. The age of the parents of 
involved children was greater than average as compared to the controls in the study by Wynn-Davies 
and Gormley. 25 
 
Trauma and transient synovitis 
The terms irritable hip, transitory hip arthritis, ‘ observation hip’, transitory coxitis, coxitis serosa 
seu simplex, acute transient epiphysitis, toxic synovitis and transient synovitis have all been used by 
various authors to describe this common and fleeting disease of childhood. At initial presentation, 
transient synovitis and Perthes’ disease may be indistinguishable. The argument supporting the theory 
that transient synovitis causes Perthes’ disease is that the intracapsular pressure that is caused by the 
synovitis often exceeds the venous pressure and this may cause a venous tamponade resulting in 
avascular necrosis of the epiphysis.  
The key feature is that there is a synovitis that often gets better in 10 – 14 days and most by a 
few weeks. As quoted by Valderrama, in his review of the “observation hip” from the Nuffield 
orthopaedic centre, Edwards in 1952 thought this to be a “reaction to infection’ or “allergic 
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hypersensitivity” to and infection elsewhere in the body but sometimes the condition followed an injury. 
From a total of 189 children an arbitrary follow up of 30 years was decided and 23 children with a 30 
year follow up were examined- three had bilateral hip involvement at different periods. They suggested 
that the “ observation hip “ syndrome is the result of an inflammatory process of the joint due to varied 
etiology, most often from either injury or infection. They noted developmental and degenerative 
changes which they felt were a consequence of hypervascularisation of the bone secondary to the 
synovitis. These changes may develop without necessarily producing the epiphysial necrosis. 
characteristic of the first stage of ischaemia in Legg-Calvé-Perthes’ disease. The persistence of this 
stage of hypervascularity, and therefore the possible outcome of the transient synovitis, may be 
conditioned by the age at onset of the pathologcal process, the severity of the condition, and the 
duration of the symptoms and signs. 81 
Adams in his study of 50 children from South Africa noted that the children with transient 
synovitis and those who were initially diagnosed to have Legg-Perthes’ disease had much the same 
age distribution but the length of the history was considerably longer in Perthes’ disease. Ten percent of 
the patients with Legg-Perthes’ disease had normal or doubtful radiographs at the outset, and in these 
the history was shorter and the onset acute. Radiographic changes always developed as the condition 
progressed. Injuries were recorded in a higher percentage of children with Legg-Perthes’ disease (19 
per cent) than those with transient synovitis (12 per cent). 82. 
Perthes’ disease can follow a transient synovitis, but not all cases are so affected. It is reported 
to occur in up to 12 % of children who had had transient synovitis of the hip by Wynne Davies and 
Gormley. 25 
Landin et al, in a prospective five-year study from Malmo, found 294 episodes of acute 
transient synovitis of the hip in 275 children. The risk of recurrence was 20 times greater than the risk of 
having a single episode. Perthes’ disease was diagnosed from one to five months after the acute attack 
of synovitis in 10 cases (3.4%). Review of the initial radiographs revealed signs of avascular necrosis in 
three of the 10 cases, and an increased joint space in five. Only two cases had completely normal 
radiographs. The value of routine radiographs taken after three months was minimal. Factors 
associated with the incidence of Perthes’ disease included prolonged time in traction before the range 
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of hip movement became normal, increase in joint space on the initial radiographs and the recurrence 
of hip symptoms after initial relief. 83. 
Pillai et al in 2005 reported that in 40 children with Perthes’ disease from South West Scotland 
history of antecedent trauma was noted in 12.5%. 19  
Kallio et al in Helsinki studied 119 children prospectively with transient synovitis or any other 
cause for synovial effusion and elevated intra-articular pressure. During a follow-up of one year not one 
case of Perthes’ disease was diagnosed and the late clinical and radiographic changes were minimal 
with moderate overgrowth of the femoral head in 33% and widening of the joint space in 14.2%. They 
felt that their results did not support the concept that Perthes’ disease develops as a result of the period 
of elevated intra-articular pressure found in transient synovitis.84. 
They had two patients with transient synovitis in one hip and symptom-free Perthes’ disease in 
the other hip which they thought was coincidental. Three of the 18 patients excluded with Perthes’ 
disease had been initially diagnosed as having transient synovitis, but in all three retrospective analysis 
of the original radiographs showed minor changes, such as a slightly widened joint space with a 
subcortical clear zone after which they were classified as not having synovitis but early Perthes’ 
disease instead. The reason why this was done was not clearly explained. They felt that Perthes’ 
disease may be misdiagnosed as transient synovitis because of scanty or absent radiographic changes 
and radiographic progression may then be a misinterpretation as development of Perthes’ disease after 
transient synovitis. They also felt that the treatment of transient synovitis by traction with the hip in 
extension had caused a high intraarticular pressure causing Perthes’ disease in some patients.  
The serum immunoglobulin levels in Perthes’ disease was examined by Joseph et al and he  found 
that there were significant increases in IgG and IgM were seen In Indian children with Perthes’ disease 
in  both boys and girls as compared to age and sex matched controls. Matsoukas’ study showed an 
increase in increase in IgG in Perthes’ disease, whereas in the former study both IgG and 1gM levels 
were raised. 85,  86,. 
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  Congenital factors 
10.7% (32 / 310) of children investigated by Wynne-Davies and Gormley had a breech birth or 
other malposition or had had a version late in pregnancy as opposed to 2 - 4% in the normal population. 
This could have been the first in a series of minor traumatic episodes in some additional cases. 25   
Catterall, Lloyd-Roberts and Wynne-Davies reported an increased frequency of congenital 
abnormalities of the genito-urinary tract, both in patients with Perthes’ disease and in their near 
relatives, and noted that the chondrogenic cells associated with the mesonephros eventually 
contributed to the formation of limb girdle cartilage. Thus, in some instances of the disease there could 
be a primary deficiency either in these cells or in their blood supply. 87, Wynne-Davies and Gormley 
reported that 10 male patients had inguinal hernias and there were 4 instances of congenital defects of 
the kidney, the ureter or hypospadias in 310 patients with Perthes’ disease. 25 There was definite family 
occurrence of renal tract abnormalities in the families of the patients indicating a probable inheritable 
congenital renal tract defect. 
In the spine, Katz found a high incidence of spina bifida occulta (82 per cent) in 178 children 
with Perthes’ disease. Examination of a control series of eighty-nine patients with “all varieties of 
orthopaedic disorders other than Legg-Calvé-Perthes’ disease”, showed the incidence of spina bifida 
occulta to be 67 per cent. Katz concluded that there was no evidence to prove a relationship between 
spina bifida occulta and Perthes’ disease. 88. 
It has been established that some congenital abnormalities show a social class gradient, being 
more frequent in the children of unskilled workers. Hall, Harrison, and Burwell, in their consecutive 
series of ninety boys and forty girls from the Birmingham area found a remarkable similarity of the 
incidence of minor anomalies in children with Perthes’ disease to that in babies with a single major 
congenital defect. This invites the speculation that there is a major congenital defect in these children 
which in some way makes the hip susceptible to Perthes’ disease at a later date. 89. 
 Loder et al have linked Perthes’ disease with behavioral profiles and found this to be 
associated with attention deficit hyperactivity disorder. 90. 
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The power, too, to study correctly what has been written, I 
consider to be an important part of the art of medicine.  
 
Hippocrates 
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IV Material and Methods 
IV.i. Study design 
This study was a prospective case control study that was based on the diagnosis of Perthes’ 
disease in the setting of the outpatient department of our Paediatric Orthopaedic clinic. We assumed 
the prevalence of disease for our study to be 0.4/100,000. 17 There are no population based studies for 
the exposure factor- i.e. thrombotic factors. The data from our clinical pathology lab suggests that the 
incidence of DVT in our population is around 7/100,000. The risk of having thrombotic tendencies in a 
subpopulation with DVT is 60% (Unpublished data 2005-6, Christian Medical College, Vellore).Thus 
extrapolating from this the average prevalence of the exposure factor is 4.2/100,000.The prevalence of 
thrombotic tendencies among the subpopulation with Perthes’ disease varies with several studies- from 
75% to 12%. Using the Epiinfo statistical package we calculated a sample size of 17 cases for 95% CI 
and 80% power using the same number of controls. 
IV.ii Definitions 
1. Perthes’ disease was diagnosed based on both radiological and clinical features. Clinical 
features were hip pain, referred pain to the knee, limp and limitation of movement in association 
with radiological features of avascular necrosis of the capital femoral epiphysis. 
IV.iii Sample selection 
1. Cases: Children with Perthes’ disease. 
a. Severe disease: Classified as either Salter Thompson B, Caterall group III or IV, or 
Herring’s Type C if the patient presented to us with collapse. As the subchondral fracture 
line was not visible in some cases it was not possible to classify each individual case into 
the Salter Thompson classification. The stage of the disease was classified using the 
modified Elizabethtown classification as reported by Joseph et al. 91,  92, 93,100. 
b. Familial Perthes’ disease – if at least two siblings had Perthes’ disease. 
 47
c. Recurrent Perthes’ disease. 
2. Exclusion criteria 
a. If the patient had chronic infection as this is known to raise the clotting factor levels as 
a part of the acute phase reaction. 
b. If the patient had surgery within six months of presenting to us which may raise the 
levels of clotting factor levels as a part of the acute phase reaction. 
c. Children with ‘mild’ Perthes’ disease were not included in the work up for thrombosis. 
IV.iv  Radiological classification 
This was done as described earlier. The Caterall classification gauging the extent of femoral 
head involvement was used and group III and IV disease was classified as severe involvement. 
Herring’s classification was used to assess the lateral pillar and Herring C was classified as severe 
disease. The Salter-Thompson classification which uses the extent of the subchondral fracture line 
was also used and all type B were classified as severe disease. We used the modified Elizabeth 
town staging as suggested by Joseph et al. 91,  
IV.v  Thrombophilia Testing 
d. The cost of doing the thrombophilic work up was Rs.9300/-, we decided to include only 
the children with severe disease. Since the tests were expensive, the levels of the 
factors in cases were first analysed to see if they fit into the internationally accepted 
standards for normal factor levels. If there were any values above the cutoffs for the 
normal values, the tests were run on the controls as well. Only the fibrinogen and 
protein S free levels were found to be totally within the normal range and so control 
values were not done for them. All the other factors had values close to the cut off 
values for normal and controls were done for these as we wanted to establish if there 
was a relationship between the absolute values of the tests and the tendency to 
develop Perthes’ disease.  
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e. Blood collection: All cases had their blood collected after a 12 hour fast in the morning 
between 8.00 and 9.00 am to reduce the effect of circadian rhythms on the levels of 
factors. The samples were drawn for both the DNA based tests and the thrombotic 
work up at the same time. Informed consent was taken from the parents at the out 
patient department. 
f. Samples: the samples were centrifuged at 3000 for 40 minutes and snap frozen at -86° 
Centigrade for testing at a later date. The DNA Samples were processed the same day 
in the Department of Haematology. 
g. The machine used for analysis and the reagents for the prothrombin and Partial 
thromboplastin time was from the Instrumentation Laboratory (Milan, Italy). The 
reagents and analysis of Fibrinogen, Factor VIII,  and APCR was also from the 
Instrumentation laboratories. The reagents for DRVVT was from Gradipore(Life 
Diagnostics, French’s Forest, NSW, Australia). The reagents for Protein C and 
Antithrombin were from Dade-Behring, Marburg, Germany. Protein S was evaluated 
using an ELISA kit sourced from Dako (Denmark).The  free Protein S was done using 
reagents from Coregenic, Westmin, Germany. Sickle cell and paroxysmal nocturnal 
haemoglobinuria was evaluated at the special test labs. 
3.  We also collected data on the age, sex, address, anthropometry( height and weight), family 
history of disease, trauma and fever, as well as coexisting disease. 
4. Statistical analysis 
a. The Fisher’s exact test was used for categorical variables and the students t-test for normal 
and Mann-Whitney U test for the non normal continuous variables. All values are expressed as 
the mean ± Standard Dev (continuous variables) or as a percentage of the group they were 
derived from( categorical variables). All p values of ≤ 0.05 were considered to indicate statistical 
significance. This was calculated using the software package SPSS Version 9 for Windows.  
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Number of cases and number of controls 
 There were 20 cases and 23 controls. The radiographs and other data were analysed for 20 
cases. 
 
Age 
The mean age of presentation of children with Perthes’ was 7 years and 8 months (range 3 to 
12 years). The duration of symptoms was calculated and this was taken into consideration to calculate 
the probable age of onset of the disease- the reason being that most of our cases had already 
undergone treatment elsewhere prior to coming here. The mean probable age of onset of disease was 
7 years and 2 months. (Three children presented six months after onset of symptoms, 3 children 
presented eight months after onset of symptoms, one child presented 3 years later, one child presented 
3 years and eight months later, the rest presented within 2 months of onset of symptoms). The 
distribution of cases according to age of onset of disease is given opposite. 
MALE: FEMALE RATIO 
There were seventeen boys and three girls in our study. The findings on our study showed a 
male:female ratio of 5.6:1.  
GEOGRAPHICAL LOCATION 
 The geographical location was mapped on both the map of India and in the state map of West 
Bengal as most of our cases were from there. 
 
STAGE -  MODIFIED ELIZABETH TOWN STAGING 
Most of our cases presented to us in stage 2A( 35%). 20%  of our cases had already reached 
the stage of reossification when they sought treatment with us.  
HERRINGS CLASSIFICATION 
We had classified Herrings C as severe disease and 12 of our cases presented with Herrings 
C. Six of our cases had Herring B of which 3 progressed to Herring C during the course of treatment 
here. Two cases with herring A on presentation had progressed to grade C disease during the course 
of treatment. 
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SALTER THOMPSON CLASSIFICATION. 
Only six had a clearly defined subchondral fracture line - all these were classified as having 
grade 2 ST disease. The rest fell under one of the three following categories:-  
A- Were operated  on before collapse/delineation of  subchondral fracture line as 
decisions were made on the basis of age and degree/severity of involvement  
B- Had severe collapse without suchondral fracture 
C- Came in Stage 3 disease i.e. when the disease was in the healing phase. 
CATERALL GRADING 
Sixteen out of twenty one ( 76%) children had group four disease. Three cases had group three 
disease and one patient had group one disease. He was classified as severe disease as the collapse of 
the lateral column was greater than 50%.  
HEAD AT RISK SIGNS 
Gage Sign   
 Eleven of the twenty cases had gage sign positive. Six had no gage sign. Three cases were in 
the healing stage and therefore could not be commented on.  
 
Lateral extrusion 
Twelve cases had lateral extrusion, 8 did not. Some of these cases developed lateral extrusion 
that became obvious after surgery. 
 
Horizontal growth plate 
 Eleven of our cases had a horizontal growth plate on X-rays. Eight cases had no horizontal 
growth plates, in one patient it was difficult to comment on the growth plate as he came in stage III B. 
All those cases who had a horizontal growth plate also had lateral extrusion except three i.e. if 
there was an adduction deformity there was very likely a lateral extrusion of the head as well. 
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Metaphyseal cysts 
All cases defined as having severe disease had metaphyseal cysts except two - the severity of 
disease correlated well with the incidence of metaphyseal cysts – suggesting that there was severe 
involvement of the epiphysis. If metaphyseal cysts are visible, it is very likely that the patient had a 
severe disease. 
Three of the cases had only one head at risk sign. All the others had atleast two. ( two signs – 
seven cases, three signs- five cases, four signs- 5 cases.)  
Trauma and infection 
Only three cases had a definite history of trauma (14%). Three other cases had a definite 
history of fever. One patient had a history of rheumatoid arthritis that was diagnosed after the diagnosis 
of Perthes’ was made. She was started on steroids eventually. 
 
Thrombophilia testing 
Protein C 
 The normal values of Protein C levels are 50-150% . All values were normal and there was no 
significant difference between cases and controls. The values of Protein C had skewed (non normal) 
values and therefore were evaluated using the Mann-Whitney U tests. The mean value for protein C in 
cases and controls was 92.3 and 123 with SDs of 16.5 and 122 respectively. The difference between 
the two was not significant.( p value of 0.26)  
Protein S 
The normal values of Protein S total are between 60-140% and the values of free Protein S are 
between 50 – 150%. 
Protein S total and Protein S free were evaluated in the cases first. The protein S total values 
were found to be normal and therefore controls were not done. The protein S free values were 
evaluated in both cases and controls and there was no significant difference between them. The value 
for protein S total was 89.3 ± 17.9  in cases. The values for Protein S free was 88.68 ± 32.4 in cases 
and 98.34 ± 43.8 in controls.  
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There was difference in the values between the controls and the cases when the two tailed t-
test was used but this was not significant ( P=0.421).  
Antithrombin ( AT) 
The normal values for AT are between 80-120%  
The  values for the controls was 131.58 ± 12.2 and the values for the cases was 118.3 ± 26.8 . 
There was a significant difference between the two (p= 0.03).   
 
Sickle cell and Paroxysmal nocturnal Haemoglobinuria. 
None of the cases or controls tested positive for either of these. 
Fibrinogen 
 The normal values for fibrinogen are 150-450%.  The mean value in cases was 267.5 % with a 
SD of 41.5.There were no values above 350 and none below 200. There was not a single patient who 
was an outlier- and hence no controls were done.  
Factor VIII 
 The normal levels for F VIII is between 50-150%. 
 The values of Factor VIII had skewed ( non normal) values and therefore were 
evaluated using the Mann-Whitney U tests. The mean values of  FVIII for the cases was 190.2 ( SD – 
116.4) and the controls was 114.2 SD – 36.5). There was a highly significant difference between the 
two with a P- value of 0.002. 
Eleven (Fifty five percent) out of 20 cases had a value above 150% as against only 3 (13%) of 23 in 
controls. Using a cutoff of 150% as normal, a two tailed analysis was done using the Fishers exact test 
and the difference was significant with a p value of 0.008.  The odds ratio of a person with Perthes’ 
disease having a FVIII value above 150% was 8.14 ( 95% confidence interval of between 1.9-36.5) 
 
Activated Protein C resistance (APCR) and Factor V Leiden mutation 
Activated protein C values are calculated using the gold standard – as the time taken by a 
person with a homozygous mutation of Factor V Leiden mutation in the test. The values in our lab were 
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1.2 to 2 with an absolute value of 2 being taken as the cut of value for normal thrombosis. The mean 
value for the controls was 1.96 with a SD of 0.237 and mean for the cases was 2.95 and a SD of 0.46.  
 These two variables are interconnected as the FVL mutation is the commonest cause for 
APRC. There are undetected causes for APRC as well as other uncommon mutations that affect 
APRC.  There was a significant difference between the values of the cases and controls. The values for 
the cases was lower in the controls than the cases. (1.96 vs 2.96, standard dev of 0.23 and  0.46 
respectively.)  
 
Prothrombin 20210 mutation 
 There were no positives in either of these in both the controls and the cases. 
MTFHR mutation 
Three cases had the MTFHR 677 mutation of which one was homozygous for the mutation and 
two were heterozygous for the mutation. None of the controls were positive.   
Anti Phospholipid antibody syndrome 
 Three of the cases had a mild positive DRVVT test for anti phospholipid antibodies 
Risk factor analysis 
 All the cases with any positive risk factor for thrombosis were evaluated separately. Cases were 
analysed for atleast one risk factor - thirteen of the cases had at least one positive risk factor for 
thrombosis (65%). Only 2 of the controls had any risk factor for thrombosis. The Fishers exact test (two 
tailed) was done to analyse the odds ratio for this and there was a highly significant ( p- 0.0002) chance 
that the children with Perthes’ disease would have a concomitant risk factor for thrombosis. The Odds 
ratio for having a risk factor among children with Perthes’ disease was 19.5 ( 95% CI of 3.5 – 108.5).  
Combined Risk factor analysis 
Twenty five percent of all the cases had atleast 2 independent risk factors for thrombosis 
versus none in the control group. This is significant as there is an additive effect for thrombotic factors 
on the incidence of thrombosis itself.  
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DISCUSSION 
 
 
 
 
 
Perhaps, then the time is ripe for us to turn full circle and recall two 
questions which Legg (1910) asked himself about this disease. “Is this 
condition the result of congenital deformity or faulty development? Is it the 
result of a constitutional disease?” 
 
R. Geoffrey Burwell   EX49  
 
…but one thing that we need to change 
is the one thing that we can change and that 
is the eventual shape of the femoral head. 
 
Salter RB. EX103 
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Discussion  
Perthes’ disease is at present considered to be of multifactorial origin. 89. In India very little work 
has been done on the epidemiology or etiology of Perthes’. Most of the work done on Perthes’ disease 
has been done in Manipal in the Konkan region by Chacko et al , Joseph et al and Rao et al 91, 85, 17, 24 , 
101). They have shown that this disease occurs in the western region of India, in the coastal belt, with 
an incidence of 4.4/100,000/year. The male:female ratio as reported by Chacko et al was 2.58:1 and 
the age at onset of disease was  10 years 24. There is a retardation of growth in these children with 
Perthes’ disease that was most pronounced in the feet.95,  Joseph et al noted that about 50% of their 
cases had severe disease  91,. However, there has been no investigation so far on the etiology of 
Perthes’ disease in India except in relation to the disturbance in growth, immunoglobulin assay 85,  and 
rural–urban differences 95,    
Data from the other countries has implicated somatomedin levels, immunoglobulin levels and 
thrombophilic factors such as protein C, protein S, hypofibrinolysis, Antiphospholipid antibodies, 
antithrombin deficiency  and factor V mutation. (77, 85,, 86,, 10, 2, 1, 3) . There have been an equal number of 
studies that refute the involvement of the above in causation of Perthes’ 5, 4, 6,7. 
A number of experimental studies carried out on dogs show that arterial and venous thrombosis 
can reproduce the histological and radiological picture of  the bone infarct seen in Perthes’ 
disease(EX30, 62,61,69). It has been categorically demonstrated that a single episode of thrombosis does 
not lead to changes of Perthes’ disease in animals. The effect of the first infarct is often transient. The 
second infarct is required to produce the characteristic radiological collapse which occurs in Perthes’ 
disease. The observations on the human Perthes’ histology using core biopsies showed multiple 
infarcts in various stages of healing occurring in the same femoral head, indicating that it is, indeed, the 
result of recurrent insults 26. Such a picture fits in with a systemic pathology rather than a local insult of 
traumatic etiology. Venous or arterial occlusion can be caused by thrombophilia due to smoking, PNH, 
autoimmune disease and anti phospholipid antibody syndrome, obesity, immobilization, and 
dysfibrinogenemia among other causes (58,60). A genetic basis for thrombosis has been considered in 
Perthes’ disease, however, findings such as the male predominance have baffled investigators. Till 
recent years, other than indirect observation and statistical models, there was little scope to prove the 
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genetic basis for Perthes’ disease. Since the occurrence of Perthes’ disease in families does not fit in to 
the inheritance pattern that is classical of a recessive or dominant single gene transmission, it follows 
that Perthes’ must be of multifactorial origin.  The low incidence of Perthes’ in twins points to another 
contributory cause. This, then, can be explained only by both a genetic as well as a local pathology.   
In Perthes’ disease, the femoral head is susceptible to insult by a thrombotic phenomenon 
more than any other site because of its peculiar blood supply and its temporal change in the growing 
child. Below 5 years, the blood supply of the femoral head is almost entirely derived from the 
transphyseal and the lateral epiphyseal vessels. At around five years, the physeal vessels undergo 
attrition and the supply is derived mainly from the lateral epiphyseal vessels, except for a minor 
contribution from the medial metaphyseal vessels. From five to nine years, the head is at risk as only 
the lateral epiphyseal vessels contribute any blood supply of significance. At nine years, the vessels of 
the ligamentum teres begin to grow and provide a significant contribution near skeletal maturity. At 
skeletal maturity, the physeal plate disappears and there is an additional intramedullary supply to the 
head of the femur. (63, 65, 28) In Perthes’, it has been shown that the growth rate is decreased, in the 
preadolescent period when the child is affected by the disease. 75 95, It is possible that this delay in 
growth mirrors a similar delay in the evolution of the blood supply of the femoral head. Children with this 
slowed growth pattern due to any cause may have an increased susceptibility to AVN and therefore to 
Perthes’ disease.  
Effusion in the hip joint can occur due to many causes. Trauma, transient synovitis, infection, 
reactive arthritis, hemophilic arthritis 82, 83,84. are some of the causes seen in the paediatric age group. In 
addition, the unyielding capsule of the hip in the extended position increases the pressure and further 
compromises the blood supply when there is an effusion 62,61, 28.This forms the third contributory factor 
in our understanding of Perthes’ disease etiology. It appears that the presence of more than one factor 
would precipitate the infarction of the femoral head. 
This study has tried to look at thrombophilia, a major contributory factor in Perthes’ disease. As 
mentioned earlier, there has been divided opinion as to the contribution of thrombotic factors. None of 
the studies that have been done have examined all thrombotic factors comprehensively. The 
understanding of the role of factor eight in thrombophilia has come about only in recent years, and this 
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has not been looked at in past studies. We have looked at all known thrombotic factors except TAFI 
(thrombin activable fibrinolysis inhibitor), and Tissue plasminogen activator inhibitor. There is a 
difference in the incidence of thrombophilic factors in the various populations as discussed previously. 
We believe that the reason why studies have negated the association between Perthes’ disease and 
thrombophilia is because a comprehensive screen was not done. 2, 3, 4,5,, , 6,7, ,8,9, 
The importance of investigation into the role of thrombophilia in Perthes’ disease cannot be 
underestimated- as an understanding of this etiology is likely to open up new treatment avenues both to 
prevent disease, as well as to arrest progression of disease. As of now, investigations for transient 
synovitis investigation do not include the study of thrombotic factors. A repeat attack of transient 
synovitis in a patient with a previous history could be the precipitating event that causes the second 
infarct resulting in Perthes’ disease. So, to prevent Perthes’ disease, action will need to be taken at or 
during the first attack of synovitis. Investigating for Thrombophilia during the first attack of synovitis 
could provide us with a window period to treat patients before they develop flagrant Perthes’. The 
identification of this ‘pre Perthes’ stage would allow us to formulate a preventive plan.  
This study focussed on thrombophilia but also made an attempt to define the distribution of 
population. More than 50% of our children with Perthes’ disease came from West Bengal (11/20).  The 
previous reported areas of high incidence in India are the Konkan region and Kerala. Our mapping 
reveals a probable focus in the east coast of India like that on the West coast as reported by Joseph et 
al. 17  To conclusively prove a high incidence in this area would require a population based study. 
The mean age of our patients at onset of disease was 7 years and 8 months and the age of 
onset of symptoms was 7 years and 2 months. This is higher than that reported in the western 
literature, ex103, 18,19,75., but lower than that reported from India 91,. It is possible that there are regional 
differences between the west coast and the east coast of India because of difference in the etiological 
cause.  
Our boy:girl ratio of 5.6:1 was close to the range quoted by most studies 24 ,17,25,18,19,20,23,22,. The 
male predominance of Perthes’ disease has not been satisfactorily explained before. Factor VIII 
elevation was implicated as a cause for thrombosis only in 1994. Factor VIII has been shown to be an 
independent risk factor for thrombosis and that there is familial clustering of cases with high FVIII levels. 
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36, 39). In our study, 11 of the 17 boys had elevated factor VIII levels. Factor VIII elevation was first 
implicated as a cause for thrombosis in 1995. 39  The previous studies on Perthes’ disease looking for 
thrombotic etiology have not studied the effect of this factor and therefore its role has not been 
documented so far. This is a major finding in our study that has not reported in the literature in 
association with Perthes’. 25,2,1,3,7,4, In our study there is a highly significant difference in the values of 
FVIII between patients and controls. (p- 0.0002). The odds ratio of a child having an elevated FVIII in 
our children with Perthes’ disease was 8.14( 95%CI of 2-36). The observation that FVIII was present in 
11 boys out of 17 and none of the three girls was not statistically significant with a p-value of 0.07. This 
is probably due to the fact that there were very few girls in our study. Since Factor VIII gene is coded on 
the X chromosome, we are able to postulate that a male predominance is probably based on an X-
linked genetic abnormality. This could then explain the high boy:girl ratio recorded in all studies.  
Fifty five percent of our patients came from West Bengal (11/20). The others were distributed 
among Tamil Nadu, Jharkhand and Kerala. Coastal Kerala has been identified as an area having a 
higher incidence. The greatest number of patients outside of West Bengal has been from Vellore inspite 
of the low incidence previously reported from this area. It is possible that there was a low rate of 
diagnosis in the past. A school survey in the community is required to asses the true incidence of the 
disease in Tamil Nadu. That a  large proportion of patients come from West Bengal and nearby 
Jharkhand (13/20) raises the possibility of another locus of disease in that region. A larger study is 
required to assess this. Pockets of high incidence have been reported elsewhere 21,20,. Such pockets 
raise the possibility of locally occurring environmental factors such as diet.  
Hyperhomocystinemia is one of the factors which lead to thrombosis due to vessel wall damage 
32, 33, 34, 35. It is known that in hyperhomocystinemia administration of vit B12, B6, and folate is known to 
reduce the levels of homocysteine 35. Conversely, it is possible that a dietary deficiency of any of these 
three vitamins may cause elevated levels of homocysteine. Three of  our patients had enzyme MTHFR 
mutations (one homozygous and two heterozygous) that leads to elevated levels of homocysteine in the 
blood and therefore are known risk factors for thrombosis. In only one previous study has this enzyme 
mutation been looked for in Perthes’ disease. It is a known mutation that has been implicated in arterial 
 60
and venous thrombosis in the Indian population and in children. 44,50,. Our study establishes it as one 
possible etiological factor that contributes to Perthes’ disease in India.  
It has been observed that one of the differences between Indian and Western populations is the 
predominant rural distribution in India. We postulate that one of the etiological agents could be 
hyperhomocystinemia. A significant part of our rural population is vegetarian and this could influence 
the levels of Vitamin B6, Folic acid levels and B12 levels in their diet. In the homozygous mutation 
hyperhomocystinemia is likely. The cases who had the heterozygous mutation will need further 
investigation i.e. homocysteine levels. Being a case control study, the fact that there were three cases 
with defects in the MTFHR gene poses a statistical problem as there were no controls with positive 
results. It is difficult to assess the level of clinical significance of each individual finding as the 
population values for these mutations are not known. 
 Antithrombin is a factor which inhibits the action of thrombin on fibrinogen- thus preventing clot 
formation.  Low antithrombin levels would enhance thrombosis 58,60). One of our patients had a 
significantly low value of 19.9% - considered to be a significant risk factor for thrombosis. Incidentally, 
he was also homozygous positive for the MTFHR gene mutation which is a significant risk factor for 
early arterial and venous thrombosis. There was an elevated antithrombin level in the controls as 
compared to the patients. (p-value was 0.03). The clinical significance of this is not understood. That 
the values of children are normally lower than adults is known. If the absolute reduction of the levels is 
what actually matters, this is of concern as no baseline values for children have been established yet. 
Current estimates of values in children have been estimated using extrapolation. The importance of this 
data will need to be examined from the viewpoint of the relative levels of other clotting factors – a 
further population based study is needed. 
The major work on thrombophilia in Perthes’ disease has been done by Glueck et al. Their 
principal findings were that up to one-third of 64 children with this disorder had resistance to activated 
protein C (APC), currently the commonest reported cause of inherited thrombophilia. However, only a 
half of the children with APC resistance, 12 in all, had a confirmatory polymerase chain reaction (PCR) 
to show that resistance was due to the presence of the factor V Leiden (FVL) mutation. Eight had the 
mutation with one homozygote. In the control group the prevalence of this factor was only 1%. In a later 
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paper, the same group showed that the ‘standard’ APC resistance assay used to screen for the FVL 
mutation was a poor predictor of the mutation. Ideally, a ‘modified’ assay should be used which adds 
factor V deficient plasma and therefore dilutes out other abnormalities which may affect the activated 
partial thromboplastin time. An additional finding was an apparently ‘low’ protein-C antigen level in 28% 
of the 64 patients studied by Glueck et al but the authors did not use age-adjusted normal ranges for 
protein C. These take account of the normal physiological deficiency which is present until adulthood 
and their use would have diminished the number of patients with apparent low levels. 1 55, 
` Though the activated protein C resistance is the commonest cause and the factor V Leiden the 
commonest mutation discovered to cause thrombosis in the western population, there were no 
significant differences in the values for protein C between patients and controls in our study. The value 
of Protein C is known to be lower in children and reach adult levels approximately by age 1147.Protein S 
Values were also normal in our patients. This indicates that there may be a wide variation in the causes 
leading to thrombosis in different populations and that each population needs to be investigated 
separately.  
None of the other factors examined were positive. The tests for sickle cell , Paroxysmal  
nocturnal haemoglobinuria, Factor V Leiden mutation  and the Prothrombin  20210 gene mutation were 
negative in both the patients and controls. The fibrinogen levels were also within normal levels. 
Anticardiolipin antibodies have been associated with adult osteonecrosis. 57. There is no reason 
to suppose that there is a difference in thrombotic factors causing Perthes’ in children and avascular 
necrosis in adults. In our study population of 20 cases, there were three children who had tested 
positive with the DRVVT. The DRVVT measures the significance of antiphospholipid antibodies. 
Though the significance of an isolated DRVVT positive result is doubtful, the fact that all those who 
tested positive also had another risk factor as well is significant (all of them had concomitantly high 
values of FVIII).  
Thrombosis is a multicausal disease and the risk of thrombosis increases synergistically with 
the addition of risk factors. For example, the annual risk for women with the factor V Leiden who did not 
use oral contraceptives was 5•7 per 10 000 people (relative risk 6•9), that for women who used oral 
contraceptives but did not carry factor V Leiden was 3•0 per 10 000 women (relative risk 3•7), and that 
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for women with factor V Leiden who used oral contraceptives was 28•5 per 10 000 people (relative risk 
34•7). 58. In this study on severe Perthes’ disease (Caterall III or IV /Herrings C), 25% of our patients 
had more than one risk factor indicating that there is a strong additive effect in Perthes’ as has been 
described in venous thromboembolism. In our study 13 out of 20 children had atleast one positive risk 
factor as compared to two of the controls. Children with Perthes’ disease had an odds ratio of 19.5 of 
having a risk factor for thrombosis and using the Fishers exact test- two tailed, there was highly 
significant (p - 0.0002) association between the two. Twenty five percent of our cases had two 
independent risk factors for thrombosis as compared with none of the controls and the significance of 
this cannot be underestimated as the effect of two risk factors is synergistic. This proves that in Indian 
children with Perthes’ disease, thrombophilia is highly likely. The factor levels of atleast one of our 
children is significant enough to require treatment immediately. There are no clear cut guidelines as yet 
on the treatment of Perthes’ with antithrombotic drugs. A large scale or multicentre study is indicated to 
establish guidelines for the investigation and management protocols in the ‘pre-Perthes’’ stage. 
 Three of our patients had a history of transient synovitis of the hip. A synovitis or effusion of 
the hip is implicated in the etiology of Perthes’ disease. A common problem in our patients is a reactive 
arthritis of the hip often caused by upper respiratory or GI infection. Potable drinking water is not 
available to most of the rural population in India. If enterically acquired reactive arthritis is taken to be 
one of the causes for reactive arthritis / 'transient synovitis' (a postulated mechanism for Perthes’ 
disease) in the hip,  it could explain the higher incidence in rural areas and in areas with the highest 
deprivation scores. EX 4, 21 Viral infective / reactive arthritis may also explain the urban clustering in 
studies from Liverpool and northern United Kingdom. It has been shown that one episode of synovitis 
predisposes a child to further attacks. There is evidence to support this in terms of elevated 
immunoglobulin levels in studies both from India and elsewhere 85, 86,). Thus, in the susceptible age 
group and the predisposed child, reactive arthritis is a risk factor for Perthes’ disease. Transient 
synovitis due to trauma may also be a contributing factor for the disease. There are two problems with 
this, one that there often is a significant recall bias associated with trauma, and two, that in the young 
child trauma may not be reported at all.  
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It was noted by Caterall et al  87, that there was an association between Perthes’ disease and 
congenital urinary tract abnormalities.  There is a similar incidence of minor congenital deformities in 
children with Perthes’ disease and those with a single major congenital defect. 89. This may be a 
manifestation of a prothrombotic tendency in the child during intrauterine growth that causes both the 
minor and major defects. We did not see any congenital defects in our patients but the number in our 
study was too small to evaluate this association. 
We conclude that Perthes’ disease is a multicausal disease with various etiological factors. 
Thrombophilia, vascular supply and hip effusion of various aetiologies are probably factors that 
influence the disease onset and severity, with those that have all these three risk factors being most 
likely to develop the disease. In our study we have looked for and found a significant number of 
Patients with thrombophilia, an etiological factor not previously studied in India. 
 Perthes believed that several different causes could lead to the obstruction of arterial blood 
flow to the affected femoral head. He and other contemporary surgeons thought that the ailment could 
arise from several different etiologic factors, operating in different individuals. 15,  Lovell and  Winter 
There probably are other factors that influence the disease such as diet, deprivation and crowding.  Our 
hypothesis takes into account all these factors. We also understand that there are probably more 
causes for the disease that have not been discovered yet.  
 
 
  
 
 
 
 
 
 
 
 
 64
 
 
 
CONCLUSIONS 
 
 
 
 
 
 
 65
Conclusions 
This study establishes Thrombophilia as a major etiological factor in Perthes’ disease in India. 
The factors that were found to be involved were factor VIII, Antithrombin, and antiphospholipid antibody. 
The genetic mutation involving MTHFR gene was involved.  
We propose that studies be carried out to frame guidelines for investigation and management, 
based on these findings.  
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Proforma 
 
Name  Age   Sex   Hosp No 
   Age at onset of symptoms 
   Age at taking blood tests 
 
Address       
 
 
Have you shifted area of origin? 
 
 
Veg/Non Veg.     
 
History 
Fever      trauma- 
       High energy/low evergy 
Previous treatment 
 
 
Examination 
Anthropometry 
Height 
Sitting height 
Subischial height 
Head circum 
Upper limb length  
Arm length  
Forarm and hand  
Ll length 
Tibia length  
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Foot length 
Biacromial dist 
Bi iliac dist 
Weight 
 
X ray classification 
Stage of disease 
Herring’s classification 
Salter-thompson classification 
Caterall grouping 
Head at risk signs 
Gage Sign 
Lat extrusion 
horizontal physis 
Lat calcification 
Metaphyseal cysts 
 
Thrombophilia work up 
Protein C  
Protein S total 
Protein s free  
Antithrombin 
Sickle cell preparation 
PNH  
Fibrinogen 
Factor  VIII  
APCR 
DRVVT 
Factor V Leiden 
Factor II 20210 
MTHFR 
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Diagrams 
 
 
 
 
 
 
 
 
 
 
 
Figure  1. Blood supply to the femoral head in a 
child aged one month. There is an  abundant 
blood supply both from the lateral as well as the 
metaphyseal vessels 
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Figure  2. Blood supply to the femoral head in a boy  
aged five years. The main blood supply is from the 
lateral  vessels. The  metaphyseal vessels now 
contribute only a minor proportion of blood supply. 
The Ligamentum teres vessels supply the head only at 
its insertion.  
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Figure  3. Blood supply to the femoral head in a boy 
aged nine years. There blood supply solely from the 
lateral  vessels. The  metaphyseal are now absent. 
The ligamentum teres blood supply begins to get 
established only later. 
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Figure  4. Blood supply to the femoral head in a boy 
aged 11 years. There blood supply is now in the 
preadolescent stage The ligamentum teres blood 
supply contributes a larger portion. When the physeal 
plate disappears the metaphyseal Blood supply gets 
reestablished 
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Figure 5. Stage 1A Part or whole of the epiphysis is sclerotic, there is no loss of height. Redrawn from  Joseph et al 
Natural Evolution of Perthes' Disease: A Study of 610 Children under 12 Years of Age ar Disease Onset, J Pediatr Orthop, 2003; 23:590-600, by the candidate. 
Figure 6. Stage 1B Part or whole of the epiphysis is sclerotic, there is no loss of height. Redrawn from Joseph et al 
Natural Evolution of Perthes' Disease: A Study of 610 Children under 12 Years of Age ar Disease Onset, J Pediatr Orthop, 2003; 23:590-600, by the candidate. 
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Figure 7.  Early fragmentation Stage 2A. Fragmentation has started. There are one ore two vertical 
fissures. Redrawn from Joseph et al Natural Evolution of Perthes' Disease: A Study of 610 Children under 12 Years of Age ar Disease Onset, J Pediatr 
Figure 8.  Late fragmentation Stage 2B: Fragmentation is advanced. There is no new bone visible laterally. 
Redrawn from Joseph et al Natural Evolution of Perthes' Disease: A Study of 610 Children under 12 Years of Age ar Disease Onset, J Pediatr Orthop, 2003; 
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Figure 9. Early reossification-Stage 3A There is new bone visible lateral to the epiphysis,  less than 1/3 of the 
epiphysis is involved, bone is porotic in nature . Redrawn from Joseph et al Natural Evolution of Perthes' Disease: A Study of 610 Children 
under 12 Years of Age ar Disease Onset, J Pediatr Orthop, 2003; 23:590-600, by the candidate. 
Figure 10.  Late reossification-Stage 3B. There is new bone visible lateral and this os of normal texture and 
more tha 1/3 of the epiphysis. Redrawn from Joseph et al Natural Evolution of Perthes' Disease: A Study of 610 Children under 12 Years of Age 
ar Disease Onset, J Pediatr Orthop, 2003; 23:590-600, by the candidate. 
. 
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Figure 11:The basic mechanism of the clotting cascade is given  
below. 
 
 
The coagulation cascade. Legend: HMWK = High molecular weight 
kininogen, PK = Prekallikrein, TFPI = Tissue factor pathway inhibitor. 
Black arrow = conversion/activation of factor. Red arrows = action of 
inhibitors. Blue arrows = reactions catalysed by activated factor. Grey 
arrow = various functions of thrombin. Bue – prothrombotic factors. Red – 
antithrombotic factors. 
PLATELETS 
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Figure 12: The functions of the antithrombotic factors are given below. 
 
 
Thrombin activable 
fibrinolysis inhibitor 
F II 
Activated Protein C 
APC inactivates 
both F V, F VIII and  
Fibrin ( Inactivated 
form – i)
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Figure 13: Virchows Triad 
 
Genes blood composition        
vessel wall                Clot/
Fibrin 
formed
Flow
Environment 
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Figure 14. Distribution of cases in India 
 
 
Figure 14. Distribution of cases in West Bengal. District wise 
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Figure 15. Age distribution of our patients. 
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Figure 16: Head at risk signs frequency among our patients. 
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Figure 17: Stage of presentation of our patients in the OD.(Modified Eliabethtown grading) 
Stage of disease at presentation, 
Modified Elizabethtown grading.
1A
10%
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2A 35% 2A  35% 
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Figure 17: Distribution of abnormal values of FVIII in controls  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Distribution of abnormal values of FVIII in patients. 
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Figure 19: Number of  controls who had any risk factor for thrombosis. 
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Figure 20: Number of patients who had any risk factor for thrombosis.
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Perthes' disease patients with more 
than one risk factor
cases, risk 
factors, 
25%
cases, no 
risk 
factors, 
75%
risk factors
no risk factors
Perthes' disease patients with more 
than one risk factor
cases,  two 
risk factors, 
25%
cases, no risk 
factors, 35%
cases, one 
risk factor, 
40%
 two risk factors no risk factors one risk factor
Fig 21: Distribution of risk factors among patients single and more than one. -65% of all 
patients had atleast one risk factor 
Fig 22: Distribution of risk factors among patients more than one risk factor. -25% of all 
patients had more than 1  risk factor 
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Our understanding of 
Aetiopathogenesis of Perthes
Environment
/diet
High risk
Thrombophilia
Joint effusion 
trauma/infection/
reactive arthritis
Vasculature -
susceptible 
age/anatomical 
variation
Unknown 
factors???
 
 
 
 
 
 
Figure 23. Our under standing of the Perthes disease etiology 
 
 
 
 
ID number name ospitalnumber SEX HEIGHT SITTING HEIGHT SUBISCHIAL HEIGHT
15 15 ABHISHEK ROY 803865C M 108 63 48
21 21 ADDYAY ROY 845348C M 128.5 67.5 61
13 13 HARUN MALIK 784022C M 151 77 74
6 6 LALTOO GOPE 587398C M 118 62 56
4 4 MANAS SINHA 649140C M 125.5 66.5 69
2 2 NASIM ANSARI 760866C M 114 61.00 53
19 19 NAVEEN 386108C M 127 67 60
7 7 NISHA KUMARI 749497C F 112 59.5 52.5
1 1 NOOR SHIKIN 654350C F 100.5 61 39
9 9 PRAVEEN KUMAR 656910C M 130.5 64.5 66
20 20 RAHUL 584496B M 150.5 74 76
8 8 RAMYA 656167C F 112 57 55
0 0 RANJAN 296950C M 165.5 86.00 79.5
10 10 RANJAN KAR 652145C M 128.5 67.5 61
11 11 ROHIT KUMAR 757643C M 127.5 68.5 59
12 12 SALEHA BEGUM'S BABY 884082B M 103 52.5 50.5
17 17 SHANKAR KUITY 540553C M 138 68 70
5 5 SUBHANKAR DEY 609221C M 133 69.5 64.5
22 22 SUDHAN 830789C M 114 60 54
25 25 UJJAL GHOSH   793386C M 124.5 60 64.5
3 3 KANNIYAMMAL 479526C F 124.5 69.5 55
HEAD CIRCUM UPPER LIMB LENGTH ARM LENGTH FORARM AND HAND LL LENGTH TIBIA LENGTH FOOT LENGTH
50.5 43.5 18 29 54 22.5 16
51.5 55 23 35 66.5 29.5 20.5
51 68 27.5 0 79 34 22
48.5 53 21.5 32 61.5 25.5 17
51 56 22 34 67 30 18.7
51.5 41 19.5 30 58 24.5 17
52 57.5 23 36.5 65 28.5 20
48.5 46 19 30 58 25 16.6
50 44 17 20 52 22 16
51 56.5 25.5 36.5 69 29 19
52 66 28.00 40 83 37.5 21.4
47.5 48 27 30 58 25 15.2
55 76.5 31.5 45.4 92.5 41.5 25.1
53 56.5 24.5 35 66 29 17.5
51 53 24 36.5 68 29 19
48.5 43.5 18 27.5 50.5 22 17.5
55 61 26.5 38 74.5 32 21.5
51.2 60 24.5 38 68 29.6 19.2
53.5 48.5 20.5 31.5 58.5 25 17.5
51 52.5 22.5 34 63 28 18.5
47.5 51.5 19.5 28 62 26 20
BIACROMIAL DIST BI ILIAC DIST WT protein c protein s to protein s freANTI THROMBIN 3 SICKLE CEPNH Fib F VIII APCR
26 18 19 86 56.7 62.3 124.6 NEG NEG 281.1 573.7 3.04
27.5 18 26.5 99.2 88.7 70.3 104.3 NEG NEG 258 389 3.03
34 25 23.5 64.7 86.1 88.8 116.6 NEG NEG 278 137.3 2.14
28 21 20 116.7 68.6 127.9 130.4 NEG NEG 267 208 3.51
29 20.5 24 121.1 85 124.5 142 NEG NEG 297 235 3.27
28 18.5 18.5 94.3 84.1 77.5 117.4 NEG NEG 265.9 67.5 3.07
30.5 20 23.5 80.5 102 78.1 96.1 NEG NEG 257 275.4 3.61
25.5 18.5 15.5 92.6 81 66.6 137.4 NEG NEG 242 138.2 2.74
25 20 25 96.9 81.7 114.3 113.2 NEG NEG 209 128 3.26
33.5 28.5 31 93.2 92.6 89.1 19.9 NEG NEG 303 70.6 2.33
32 20 31 79.7 86.2 77.7 123.3 NEG NEG 290 196 3.44
23.5 17.5 15 60.4 67.3 60.8 108.8 NEG NEG 346 140.1 3.71
37.5 23.5 47.5 89.4 79 46.5 153.3 NEG NEG 299 199 2.83
30.5 19.5 24.5 85.6 94.2 81.4 125.9 NEG NEG 213 108.3 3.04
33 28 35 86.7 134.4 103.1 136.9 NEG NEG 288.9 136.4 2.47
27 16.5 38 91 83 103.3 124.8 NEG NEG 256 195.5 2.04
31.5 23 28.5 106.7 123.3 92.8 111.2 NEG NEG 205 166.3 3.15
31.5 20 25 123.4 107.5 187.7 125.5 NEG NEG 349.6 96.7 2.62
26 18.5 23 100.4 85.5 69 120.7 NEG NEG 234 180 2.8
27 21.5 23.5 77.3 99.7 51.7 134.3 NEG NEG 211.1 163 3.05
26 19.5 25 0 0 0 0 0 0 0 0 0
DRVVT FACTOR VFACTOR II MTHFR 67 age sex age at blood testing stage modi herrings clasalterthompcaterall gra gage lat extrusio horizontal p
NEG normal normal normal 4 M 5 1B C 2 IV YES YES YES
NEG normal normal HETEROZY 8 M 8,4/12 1B B NOT DONEIV YES YES YES
NEG normal normal normal 12 M 13 2B C 2 IV YES YES YES
POS MILD-normal normal normal 6,6/12(7) M 8 1B C NOT DONEIV YES NO YES
NEG normal normal normal 8,4/12,9 M 10 2A C 2 IV YES YES YES
NEG normal normal normal 6 M 6,6/12 2A C 2 III YES NO NO
NEG normal normal normal 6 M 9 1B C 2 IV NO YES YES
NEG normal normal normal 9 F 9,6/12 2A C NOT DONEIV NO YES YES
NEG normal normal normal 4,6/12 F 5 2A B-C NOT DONEIV NO NO NO
NEG normal normal HOMOZYG8,8/12 M 9 2A B-C 2 III YES YES NO
NEG normal normal normal 7 M 11 1A B-C NOT DONEIII YES NO NO
NEG normal normal HETEROZY 8 F 10 2A B NOT DONEIV NO YES YES
NEG normal normal normal 12 M 15 1A A-B NOT DONEIV YES NO NO
NEG normal normal normal 6(9) M 10 3A B NOT DONEIV NO NO YES
NEG normal normal normal 7 M 10 3A C NOT DONEII YES YES YES
POS MILD normal normal normal 5 M 6 1B A NOT IV NO NO NO
NEG normal normal normal 104/12,11 M 13 2B C NOT DONEIV YES YES YES
NEG normal normal normal 9 M 10 3A C NOT DONEIV NO YES NO
POS MILD normal normal normal 5,6/12 M 5,1/2 2A C NOT DONEIV YES NO NO
NEG normal normal normal 3,8/12,7 M 10 3B C NOT DONEIV NO YES YES
0 0 0 0 10 F 11 2A C 2 III NO YES YES
cysts metapMETAPHY TRAUMA FEVER lat calcification Controls protein c protein s to protein s freANTI THROSICKLE CEPNH Fib
YES NO NO YES NO 1 Control 64.8 46.7 143.8 neg neg
YES NO NO NO 2 Control 50.7 54.3 129.2 neg neg
YES ? NO NO YES 3 Control 129.7 60 148.8 neg neg
YES YES NO 4 Control 126.9 68.9 122.2 neg neg
YES NO NO 5 Control 124 111.7 127.5 neg neg
YES NO NO NO 6 Control 101.5 81.4 156.3 neg neg
NO YES NO YES 7 Control 157.9 92.7 141.9 neg neg
YES NO NO YES 8 Control 132.5 104.7 124.4 neg neg
YES NO NO NO 9 Control 104.3 125.9 130.8 neg neg
YES NO NO NO YES 10 Control 121.2 63.7 121.2 neg neg
YES NO NO NO 11 Control 124 100.1 122.4 neg neg
YES NO NO YES NO 12 Control 64.8 162.4 149.8 neg neg
YES NO NO NO 13 Control 84.6 198.9 129.9 neg neg
YES NO NO YES 14 Control 76.1 112.4 129.6 neg neg
NO NO NO NO YES 15 Control 56.4 64.2 126 neg neg
YES NO NO 16 Control 70.5 77.9 124.4 neg neg
YES YES NO YES 17 Control 90.2 71 127.7 neg neg
YES YES NO YES 18 Control 64.8 66.1 130.8 neg neg
YES ? NO NO NO 19 Control 98.7 198.9 108 neg neg
YES NO YES YES 20 Control 667.6 58.6 151.7 neg neg
YES YES NO 21 Control 101.5 142.8 140.4 neg neg
22 Control 115.6 73.3 118.6 neg neg
23 Control 98.7 125.4 121 neg neg
F VIII APCR DRVVT FACTOR VFACTOR II MTHFR 677
107.4 2.06 neg neg neg neg
170.8 2.16 neg neg neg neg
136.4 2.17 neg neg neg neg
133.4 2.35 neg neg neg neg
98.6 2.12 neg neg neg neg
89.2 2.02 neg neg neg neg
76.4 1.66 neg neg neg neg
98.6 2.15 neg neg neg neg
113.4 2.13 neg neg neg neg
69.6 2.2 neg neg neg neg
87.8 2.15 neg neg neg neg
122.4 1.98 neg neg neg neg
144 2.18 neg neg neg neg
176 2.03 neg neg neg neg
120.6 2.25 neg neg neg neg
134.4 1.77 neg neg neg neg
49.6 1.68 neg neg neg neg
125.4 1.76 neg neg neg neg
148.6 1.62 neg neg neg neg
66.4 1.66 neg neg neg neg
84.4 1.7 neg neg neg neg
187.4 1.69 neg neg neg neg
85.8 1.68 neg neg neg neg
